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A B S T R A C T
Background
Clinical trials have shown that exercise in adults with overweight or obesity can reduce bodyweight. There has been no quantitative
systematic review of this in The Cochrane Library.
Objectives
To assess exercise as a means of achieving weight loss in people with overweight or obesity, using randomised controlled clinical trials.
Search strategy
Studies were obtained from computerised searches of multiple electronic bibliographic databases. The last search was conducted in
January 2006.
Selection criteria
Studies were included if they were randomised controlled trials that examined body weight change using one or more physical activity
intervention in adults with overweight or obesity at baseline and loss to follow-up of participants of less than 15%.
Data collection and analysis
Two authors independently assessed trial quality and extracted data.
Main results
The 43 studies included 3476 participants. Although significant heterogeneity in some of the main effects’ analyses limited ability
to pool effect sizes across some studies, a number of pooled effect sizes were calculated. When compared with no treatment, exercise
resulted in small weight losses across studies. Exercise combined with diet resulted in a greater weight reduction than diet alone (WMD
- 1.1 kg; 95% confidence interval (CI) -1.5 to -0.6). Increasing exercise intensity increased the magnitude of weight loss (WMD -
1.5 kg; 95% CI -2.3 to -0.7). There were significant differences in other outcome measures such as serum lipids, blood pressure and
fasting plasma glucose. Exercise as a sole weight loss intervention resulted in significant reductions in diastolic blood pressure (WMD -
2 mmHg; 95% CI -4 to -1), triglycerides (WMD - 0.2 mmol/L; 95% CI -0.3 to -0.1) and fasting glucose (WMD - 0.2 mmol/L; 95%
CI -0.3 to -0.1). Higher intensity exercise resulted in greater reduction in fasting serum glucose than lower intensity exercise (WMD -
0.3 mmol/L; 95% CI -0.5 to -0.2). No data were identified on adverse events, quality of life, morbidity, costs or on mortality.
Authors’ conclusions
The results of this review support the use of exercise as a weight loss intervention, particularly when combined with dietary change.
Exercise is associated with improved cardiovascular disease risk factors even if no weight is lost.
P L A I N L A N G U A G E S U M M A R Y
Exercise and diet produce weight loss in people with overweight or obesity
Overweight and obesity are important public health problems and are associated with many serious health conditions. The risk of
developing overweight and obesity depends on lifestyle factors such as food intake and physical activity levels. Treatment for overweight
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and obesity therefore commonly involves diet and exercise. We found that exercise has a positive effect on body weight and cardiovascular
disease risk factors in people with overweight or obesity, particularly when combined with diet, and that exercise improves health even
if no weight is lost. No data were identified on adverse events, quality of life, morbidity, costs or mortality.
B A C K G R O U N D
Description of the condition
Overweight and obesity are conditions of excess body fat
(NHMRC 1997). The World Health Organisation (WHO) de-
fines weight status according to body mass index (BMI), the ratio
of weight (in kilograms) divided by height (in metres squared).
A BMI of 20 to 25.9 defines normal weight, 25 to 29.9 defines
overweight and equal to or greater than 30 defines obesity (WHO
2003). Overweight and obesity are a major public health problem
with more than one billion adults overweight globally, 300 million
of which have obesity (WHO 2006). Increased consumption of
more energy-dense, nutrient-poor foods with high levels of sugar
and saturated fats, combined with reduced physical activity, have
led to the increase in prevalence (WHO 2003). Overweight and
obesity pose a major risk for serious chronic diseases, including
type 2 diabetes, cardiovascular disease, hypertension and stroke,
and certain forms of cancer. Effective weight management for indi-
viduals and groups with overweight and obesity involves a range of
strategies including reducing energy intake through dietary change
and increasing energy expenditure by increasing physical activity
levels (WHO 2003).
Description of the intervention
Although evidence supporting the efficacy of exercise to achieve
weight loss is disappointing, studies do support the efficacy of ex-
ercise to prevent weight gain. A number of large studies, including
the Reno diet-heart study, the “First National Health Nutrition
and Examination Survey” (NHANES-1) and the Canada Fitness
survey have found a negative association between physical activity
and weight gain (Foreyt 1995; Williamson 1993; Tremblay 1986;
Tremblay 1990). These studies were large-scale cross-sectional and
longitudinal studies. The impact of a number of vigorous and non-
vigorous leisure activities on weight was examined. People who
were habitually more active were found to be less obese. There-
fore increasing physical activity, both exercise and habitual activ-
ity, may have a role in preventing obesity, preventing worsening
of already established obesity, and reducing body mass in obese
people.
How the intervention might work
Even if exercise does not result in weight loss, it confers significant
health benefits to people with overweight and obesity. Blood lipid
profiles associated with increased risk of coronary heart disease
are a common metabolic feature of obesity. Since the early 1980s
there has been increasing evidence that central fat accumulation
has an adverse action on lipids, resulting in elevated triglycerides
and very-low-density lipoproteins and low levels of high-density
lipoproteins (Despres 1994). Exercise, with or without weight loss,
improves plasma lipoprotein status, in particular, increasing high-
density lipoproteins therefore may be of particular benefit to peo-
ple who are abdominally obese even if no weight is lost by exercis-
ing. Similarly, large cross-sectional studies demonstrate reduction
in blood pressure in those who regularly exercise, compared with
sedentary persons, irrespective of weight (Montoye 1972; Sandvik
1993). The large cohort Harvard alumni study, showed that those
who engaged in regular vigorous leisure activities had a 33 percent
lower risk (relative risk reduction) of developing hypertension and
41 percent reduction (relative risk reduction) in mortality from
coronary heart disease over 20 years (Paffenbarger 1983).
Exercise interventions ideally should be used in the context of
a multi-component weight loss program to gain their maximum
benefit. Diet and exercise combined with psychological inter-
ventions comprise an intuitively powerful weight loss program
(NHLBI 1998). However, in spite of the increased comprehen-
siveness of weight loss programs and improvements in patient ed-
ucation, understanding of the role of diet and exercise in weight
loss, psychological interventions, and improved pharmacothera-
pies for weight reduction, results of weight loss trials have con-
tinued to remain disappointing (Liao 2000). There are still ma-
jor gaps in our understanding of the roles of diet, exercise, and
psychological therapies in weight reduction. Also, achieving long-
term modification of food intake and food type by the obese indi-
vidual without creating decreases in energy expenditure associated
with dieting, and dealing with relapse to pre-intervention diet and
exercise behaviours are ongoing challenges (Brownell 1986).
Studies examining the magnitude of weight loss achievable with
exercise have shown disappointing results. Garrow and Summer-
bell, in a meta-analysis of 28 studies of exercise and weight loss,
concluded that weight lost in exercise programs without caloric
restriction is small and usually ranges from 2 to 7 kg (Garrow
1995). Ballor and Keesey, in an earlier meta-analysis, also found
that weight loss associated with exercise was modest (Ballor 1991).
However, considerable research has been performed in the area
since these meta-analyses were performed. This review aimed to
clarify the effect of exercise on body weight and health in people
with overweight and obesity, using high quality criteria to assess
and summarise the evidence.
O B J E C T I V E S
To assess the efficacy of exercise as a means of achieving weight
loss in people with overweight and obesity.
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C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
All randomised controlled clinical trials of exercise in people with
overweight or obesity, with a duration of at least three months and
loss to follow-up of less than 15%, were considered for inclusion.
Types of participants
Studies were limited to adult participants (aged over 18 years).
Studies included adults with overweight or obesity according to
body mass index, waist circumference or waist-to-hip ratio, irre-
spective of health status.
Types of intervention
The studies included had an exercise prescription. Exercise is de-
fined as any form of physical activity performed on a repeated ba-
sis for an defined period of time (exercise training). Exercise pre-
scriptions include specific recommendations for the type, inten-
sity, frequency and duration of any physical activity with a spe-
cific objective (e.g. increase fitness, lose weight) (Bouchard 1994).
Studies stating that they simply recommended increasing physical
activity were not included within the analyses unless it was possi-
ble to quantify the exercise stimulus by some means. Studies that
combined exercise and medication associated with weight loss as
an intervention were excluded.
Types of outcome measures
Primary outcomes
1. Weight or another indicator of body mass (e.g. body mass index,
waist measurement, waist-to-hip ratio);
2. Morbidity and mortality;
3. Well-being and quality of life.
Secondary outcomes
1. Serum lipids;
2. Serum glucose;
3. Systolic and diastolic blood pressure;
4. Adverse effects.
We planned on examining the following effect modifiers if there
were sufficient data: sex, age, adherence to treatment, initial weight
and co-morbidities.
Timing of outcome assessment
Studies with a duration including follow-up period of three
months or greater were included in this review.
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Metabolic and Endocrine Disorders Group
methods used in reviews.
(1) Electronic databases used included The Cochrane Library,
MEDLINE (1966 to 2005), SPORT Discus (1830 to 2005),
and EMBASE (1974 to 2005).
(2) Databases of ongoing trials used included Current Controlled
Trials (www.controlled-trials.com) and The National Research
Register (www.update-software.com/National/nrr-frame.html).
(3) The reference lists of review articles and of all included studies
were searched in order to find other potentially eligible studies.
(4) Potential missing, unpublished or ongoing studies were
planned to be sought by contacting experts in the field. This was
not necessary.
(5) Publications in all languages were sought.
Please see under ’Additional tables’ for a detailed search strategy
(Table 01).
Additional key words of relevance were sought during the
electronic or other searches. None were identified.
M E T H O D S O F T H E R E V I E W
Selection of studies
Assessment of quality and results data was undertaken by two
reviewers (KS and HCG). Full articles were retrieved for further
assessment if the information given in the abstract obtained from
the searches suggested that the study: 1. included people who
were overweight or obese, 2. compared exercise with placebo or
another non-pharmacological weight loss intervention, 3. assessed
one or more relevant clinical outcome measures, 4. used random
allocation to the comparison groups. When a title or abstract
could not be rejected with certainty, the full text of the article
was obtained for further evaluation. Interrater agreement for study
selection was measured using the kappa statistic (Cohen 1960).
Where differences in opinion existed, these were resolved by a third
party (POR). Where duplicate publications and companion papers
were located, information was maximised by using all versions of
the study.
Data extraction and management
Data extracted included the following:
(1) General information: Published/unpublished, title, authors,
source, contact address, country, language of publication, year of
publication, duplicate publications.
(2) Trial characteristics: Design, duration, randomisation (and
method), allocation concealment (and method), blinding
(outcome assessors), check of blinding.
(3) Intervention: Exercise prescription, comparison interventions
(method, timing).
(4) Patients: Sampling (random/convenience), exclusion criteria,
total number and number in comparison groups, gender, age,
diagnostic criteria of overweight or obesity, similarity of groups
at baseline, assessment of compliance or relapse, withdrawals or
losses to follow-up (reasons or description), subgroups.
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(5) Outcomes: Outcomes specified above, what was the main
outcome assessed in the study, other events, length of follow-up.
(6) Results: For outcomes and times of assessment, intention-to-
treat analysis.
A template data extraction form was developed and sent to
the Metabolic and Endocrine Disorders Group Editorial Base
for approval. Study authors were not contacted for further
information.
Assessment of methodological quality of included studies
The quality of reporting each trial was assessed based largely on
the quality criteria specified by Schulz and by Jadad (Schulz 1995;
Jadad 1996). In particular, the following factors were studied:
(1) Minimisation of selection bias - a) was the randomisation
procedure adequate? b) was the allocation concealment adequate?
(2) Minimisation of attrition bias - a) were withdrawals and
dropouts completely described? b) was analysis by intention-to-
treat?
(3) Minimisation of detection bias - were outcome assessors blind
to the intervention?
Based on these criteria, studies were subdivided into the following
three categories (see Cochrane Handbook):
A - all quality criteria met: low risk of bias.
B - one or more of the quality criteria only partly met: moderate
risk of bias.
C - one or more criteria not met: high risk of bias.
This classification was planned to be used as the basis of a sensitivity
analysis.
Each trial was assessed for quality assessment independently by
two reviewers (KS, HCG). Interrater agreement was calculated
using the kappa statistic (Cohen 1960).
Data synthesis (meta-analysis)
Where data were available which were sufficiently similar with
respect to interventions and outcomes, pooled estimates of effect
were obtained using Review Manager (RevMan) 4.2. Data were
entered into RevMan and analysed using RevMan Analyses, the
statistical component of RevMan. Fixed-effect models were used
to pool data where appropriate.
Assessment of heterogeneity
Where heterogeneity existed a random effects model was used
to explore results. Effect sized are presented as weighted mean
differences with 95% confidence intervals. The chi-square method
was used to assess heterogeneity with the significance set at p<0.1.
Heterogeneity was also examined with I2. Where I2 values of
greater than 50% were present, meta-analytic pooling was not
performed (Higgins 2003).
Subgroup analyses and investigation of heterogeneity
Should the quantity of data have permitted, we planned to examine
subgroups based on the following factors:
(1) Type, intensity and duration of the exercise intervention;
(2) Age;
(3) Gender;
(4) Smoking status;
(5) Different comparison interventions;
(6) Co-morbidities.
Sensitivity analyses
We compared the results of fixed- and random-effects models. We
also planned to perform sensitivity analyses in order to explore the
influence of the following factors on effect size:
(1) Repeating the analysis excluding unpublished studies (if there
were any);
(2) Repeating the analysis taking account of study quality, as
specified above;
(3) Repeating the analysis excluding any very long or large studies
to establish how much they dominate the results;
(4) Repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), country.
Funnel plots were performed for assessment of small study bias.
D E S C R I P T I O N O F S T U D I E S
Trials identified
The search strategy, last performed in January 2006, identified
4040 abstracts for perusal. On review of the abstracts, 271 articles
were retrieved for perusal. Of these, 89 potentially relevant studies
were located.
QUOROM (quality of reporting of meta-analyses) statement
(Moher 1999)
• potentially relevant abstracts identified and screened for re-
trieval (n= 4040);
• abstracts excluded (n=3769);
• studies retrieved for more detailed evaluation (n=271);
• studies excluded (n=182);
• potentially appropriate studies to be included in the systematic
review (n=89);
• studies excluded from the systematic review, with reasons in
’Table of Excluded Studies’ (n=46);
• studies included in the systematic review (n=43);
• duplicate publications (n=2);
• RCTs included in the systematic review (n=41).
Excluded studies
Following an evaluation of the methods and results section of the
trials, 46 were excluded from the review. These studies and their
reasons for exclusion are presented in the table: ’Characteristics of
Excluded Studies’.
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Included studies
A total of 43 studies, reporting the results from 41 trials, met
the inclusion criteria and were included in the review. The kappa
statistic for trial selection was 0.73; 95% confidence interval (CI)
0.64 to 0.82. The details of these studies are described in the table:
’Characteristics of Included Studies’. Two studies were duplicate
publications of other studies included in the review. Data from
these studies were included and were used to maximise available
information about the primary studies (Pritchard 1997; Svend-
sen 1993). Two studies compared exercise and behaviour ther-
apy with behaviour therapy alone (Jeffery 1998; Jeffery 2003). A
number of trials did not present results in a manner that enabled
variance data for change in outcome measures to be extracted.
These studies, identified in the ’Notes’ section of the ’Character-
istics of Included Studies’ table, are included in the results but are
reported narratively (Aggel-Leijssen 2001b; Aggel-Leijssen 2002;
Balkestein 1999; Gillett 1987; Manning 1991; Raz 1994; Stensel
1994; Utter 2000; Wing 1988; Wirth 1985). The data from these
studies are not included in the analyses.
Studies
All included trials were randomised controlled clinical trials. Eight
trials were factorial in design (Aggel-Leijssen 2001; Anderssen
1996; Cox 2004; Jeffery 1998; Neumark 1995; Nieman 1998;
Stefanick 1998; Wood 1991). The remaining 33 were parallel in
design.
Participants and settings
There were a total of 3476 participants in the 41 trials. All trials
were conducted in adults. The weighted mean age of participants
was 42.4 years for the 32 trials that reported age as a mean value.
The remaining nine trials, which reported age as a range, included
participants aged between 20 and 75 years. Of the 39 trials that re-
ported gender distribution of participants, 17 included men only,
15 included women only, and 10 included both men and women.
The duration of the included studies ranged from 3 to 12 months,
including follow-up.
Twenty-four trials were conducted in the United States of America,
four were conducted in The Netherlands (Aggel-Leijssen 2001;
Aggel-Leijssen 2001b; Aggel-Leijssen 2002; Balkestein 1999),
three in Canada (Janssen 2002; Ross 1996; Thong 2000) and
Australia (Cox 2004; Cox 1996; Pritchard 1997), two in Israel
(Raz 1994; Neumark 1995) and one in Norway (Anderssen 1996),
the United Kingdom (Stensel 1994), Denmark (Svendsen 1993)
and Germany (Wirth 1985), respectively. All trials were outpa-
tient community studies. None were inpatient hospital studies.
The range of outpatient settings in which trials were conducted in-
cluded general medical clinics, hospital obesity outpatient clinics,
primary care, university campuses and workplace settings. Most
participants were recruited by local news media (e.g. local newspa-
per, radio announcements, bulletin boards). One study recruited
their participants from a database of participants of a cohort study
(Anderssen 1996), one from a group of people newly registered to
participate in a concurrent lifestyle intervention trial (Hellenius
1993), one from a database of respondents to a community sur-
vey questionnaire (Svendsen 1993), and one from the staff of a
national business corporation (Pritchard 1997).
The exercise interventions that were evaluated are listed below.
Eighteen trials evaluated multiple exercise interventions within
their design, and 23 trials evaluated a single exercise intervention.
Twenty-one trials evaluated a walking intervention, 10 evaluated
cycle ergometry (exercise bicycle), eight evaluated jogging, eight
evaluated weights training, five evaluated commercial aerobics, five
evaluated treadmill exercise, two evaluated stair stepping, and one
evaluated each of dancing, ball games, calisthenics, rowing, and
aqua jogging, respectively. No trials evaluated swimming or water
aerobics as weight loss interventions.
Thirteen trials contained groups that compared exercise with no
treatment as a weight loss intervention in people with overweight
or obesity. Eight trials evaluated walking / jogging, three evaluated
cycle ergometry (Aggel-Leijssen 2001b; Cox 2004; Irwin 2003),
two evaluated weights training (Irwin 2003; Manning 1991), and
one each evaluated aerobics (Pritchard 1997) and ball games /
calisthenics (Wirth 1985). The exercise intensity was high (greater
than 60% maximal oxygen uptake (VO2 max) / maximum heart
rate) for nine trials, low (less than 60% VO2 max / maximum
heart rate) for one trial (Aggel-Leijssen 2001b), and not specified
for two trials (Stensel 1994; Wing 1998). The exercise frequency
was greater than five days a week for one trial (Thong 2000) and
3 to 5 days a week for 12 trials. Exercise duration ranged from 15
to 60 minutes with the median exercise duration per session of 45
minutes.
Eleven trials contained groups that compared exercise to diet as
weight loss interventions in people with overweight or obesity.
Seven trials evaluated walking or jogging, two evaluated aerobic
exercise of the participants choice equivalent to brisk walking or
jogging (Stefanick 1998; Pritchard 1997), one evaluated cycle er-
gometry (Cox 2004) and one evaluated aerobic exercise consisting
of either walking, jogging, aerobics or circuit training (Anderssen
1996). The exercise intensity was high (greater than 60% VO2
max / maximum heart rate) for ten trials and not specified for one
trial (Wing 1998). The exercise frequency was greater than five
days a week for one trial (Thong 2000), 3 to 5 days a week for
nine trials and 2 to 3 days a week for one trial (Hellenius 1993).
Exercise duration ranged from 30 to 60 minutes with the median
exercise duration per session of 40 minutes. Four studies com-
pared exercise with a low calorie diet (Cox 2004; Schwartz 1987;
Schwartz 1990; Thong 2000), three compared exercise with a low
fat diet (Stefanick 1998; Anderssen 1996; Pritchard 1997), and
four compared exercise with a low fat or low calorie diet (Gordon
1997; Hellenius 1993; Wing 1998; Wood 1988).
Sixteen trials contained groups that compared exercise in combi-
nation with diet to diet alone as weight loss interventions in peo-
ple with overweight or obesity. Seven trials evaluated walking or
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jogging, two evaluated cycle ergometry (Cox 2004; Hays 2004),
one evaluated step aerobics (Wadden 1997), one cycling/walking/
stair stepping (Ross 1996), one cycling or walking or aqua jogging
(Janssen 2002), one treadmill exercise or cycling or stair stepping
(Aggel-Leijssen 2001), one walking in combination with weights
training (Whatley 1994), one walking or jogging or aerobics (Neu-
mark 1995), one aerobic exercise in combination with weights
training (Svendsen 1993) and one of exercise of the participants
choice equivalent to brisk walking or jogging (Stefanick 1998).
The exercise intensity was high (greater than 60% VO2 max /
maximum heart rate) for 12 trials, low (lower than 60% VO2 max
/ maximum heart rate) for one trial (Janssen 2002) and not spec-
ified for three trials (Wing 1998; Wood 1991; Stefanick 1998).
The exercise frequency was greater than five days a week for one
trial (Neumark 1995) and 3 to 5 days a week for 15 trials. Exercise
duration ranged from 30 to 90 minutes with the median exercise
duration per session of 50 minutes. A low calorie diet was used for
10 trials, a low fat diet for three trials (Hays 2004; Kiernan 2001;
Stefanick 1998) and a low fat or low calorie diet for three trials
(Gordon 1997; Wood 1991; Wing 1998).
Eight trials contained groups that compared high with low inten-
sity exercise stimuli as weight loss interventions in people with
overweight or obesity. In seven of the eight trials subgroups of par-
ticipants were also on low fat or low calorie diets. Exercise stimuli
investigated included high versus low intensity walking (Jakicic
2003; Leutholtz 1995), step aerobics versus increasing incidental
physical activity (Anderson 1999), cycling plus treadmill exercise
plus weights training versus cycling plus treadmill exercise alone
(Wallace 1997), high versus low intensity walking plus weights
training (Whatley 1994), and treadmill exercise plus cycling plus
stair stepping versus weights training (Janssen 2002; Ross 1996).
The exercise frequency was 3 to 5 days a week for all trials. Exer-
cise duration ranged from 20 to 60 minutes in the high intensity
group and 10 to 60 minutes in the low intensity group.
Overall, trials did not differ markedly in the degree of overweight
in the patient groups. Most reported weight change as kilograms
lost. Only two trials reported weight change as change in BMI
alone (Anderssen 1996; Hellenius 1993). Weight entry criteria
for most trials included participants with overweight as well as
participants with obesity. Twenty-two trials specified weight entry
criteria according to BMI (in excess of 25 for all studies except
Anderssen 1996 and Irwin 2003 which specified BMI equal or
greater than 24 for inclusion). Eight trials specified weight entry
criteria according to percentage overweight (all between 110% to
200% according to Metropolitan Life Insurance Tables) and five
trials according to percentage body fat (all in excess of 24%). The
remainder specified weight entry criteria according to waist-to-hip
ratio (Stefanick 1998; Wallace 1997) and kilograms overweight
(Anderson 1999; Jeffery 1998;Jeffery 2003).
M E T H O D O L O G I C A L Q U A L I T Y
The methodological quality of included studies is described in the
table ’Characteristics of Included Studies’. All 43 included stud-
ies had some methodological weaknesses according to the quality
criteria applied. Only four studies (Irwin 2003;Gillett 1987; Ste-
fanick 1998; Wood 1988) reported the method of randomisation.
For the remaining studies it was not possible to tell whether allo-
cation to groups was concealed. All included studies had a loss to
follow-up of less than 15% as specified in the inclusion criteria for
the review. Blinded outcome assessment was carried out in three
studies (Irwin 2003;Anderson 1999; Wing 1988), the others were
not clear or not done. The duration of all included studies, in-
cluding follow-up, was three months or more, as specified in the
inclusion criteria for the review. Twenty-five of the 41 trials were
four months or less in duration.
Four trials suffered from potential selection bias due to the pop-
ulation from which the sample was selected being biased in some
way. Anderssen 1996 recruited the sample from a database of par-
ticipants of a cohort study, Hellenius 1993 recruited from a group
of people newly registered to participate in a concurrent lifestyle
intervention trial, the details of which were not specified, Svendsen
1993 recruited from a database of respondents to a community
survey questionnaire, the generalizability of which is unknown,
and Pritchard 1997 recruited from the staff of a national business
corporation, the nature of which is unknown.
Many trials had small sample sizes, meaning that it would have
been difficult to detect small but potentially significant differences
across groups. Two trials performed intention-to-treat analyses (Ir-
win 2003; Jakicic 2003). Allocation concealment for all trials was
categorised as ’B’, indicating that one or more criteria were not
met.
R E S U L T S
A summary table ’Summary of main findings from comparisons
for each outcome’, outlining the changes in outcome measures
within each of the comparison groups, is provided in Table 03,
original data for all outcomes in Table 02 in the additional tables
section.
Primary outcomes
No data were identified on mortality, morbidity, adverse events or
quality of life among the trials included in this review.
Weight
The effects of interventions on between-group change in weight
and body mass index (BMI) are shown in ’Comparisons 01 and
02’. Due to heterogeneity of interventions and comparisons, we
believed it appropriate to obtain pooled estimates for only two
groups of trials assessing weight: exercise and diet versus diet alone,
and high versus low intensity exercise without dietary change; and
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one group of trials assessing BMI: exercise and diet versus diet
alone.
In the group exercise plus diet versus diet alone fourteen trials
involving 1049 participants included data regarding weight loss
that were suitable for meta-analysis. Participants in both groups
lost weight across trials. The pooled effect for interventions with a
follow-up between 3 and 12 months was a reduction in weight of
1.1 kg (95% confidence interval (CI), 0.6 to 1.5) in the exercise
and diet group compared with the diet alone group. Five trials
involving 452 participants included data regarding change in BMI
that were suitable for meta-analysis. Participants in both groups
reduced BMI. The pooled effect for interventions was a reduction
in BMI of 0.4 kg/m2 (95% CI, 0.1 to 0.7) in the exercise and diet
group compared with the diet alone group.
In the high versus low intensity exercise without dietary change
group weight loss data from four trials involving 317 participants
were pooled. All trials favoured high intensity exercise for weight
loss. The pooled effect for interventions with a follow-up between
3.5 and 12 months was a reduction in weight of 1.5 kg (95% CI,
0.7 to 2.3) in the high intensity exercise group compared with the
low intensity exercise group.
Secondary outcomes
Systolic blood pressure
Pooled estimates of between-group changes in systolic blood pres-
sure could be estimated for two groups of trials: exercise versus diet
and exercise and diet versus diet alone (Comparisons 02.03 and
03.03). Four trials involving 361 participants compared change in
systolic blood pressure with exercise versus diet. All trials favoured
diet over exercise for reduction in systolic blood pressure. Partici-
pants who dieted reduced systolic blood pressure 2 mmHg (95%
CI, 0.3 to 4) more than participants who exercised (p=0.02). Six
trials involving 615 participants compared change in systolic blood
pressure with exercise and diet versus diet alone. Both groups re-
duced systolic blood pressure and no statistically significant dif-
ference between groups was demonstrated (p=0.87).
Diastolic blood pressure
Pooled estimates of between-group changes in diastolic blood pres-
sure could be estimated for two groups of trials: exercise versus
no treatment, and exercise versus diet (Comparisons 01.04 and
02.04). In the two trials that involved 259 participants and com-
pared change in diastolic blood pressure with exercise versus no
treatment, participants who exercised reduced diastolic blood pres-
sure 2 mmHg (95% CI, 1 to 4) more than no treatment (p=0.01).
In the four trials that involved 361 participants and compared
diet and exercise for reducing diastolic blood pressure, there was
no significant difference between interventions (p=0.19). Both in-
terventions resulted in clinically significant reductions in diastolic
blood pressure.
Serum cholesterol
There was one group of trials where pooled estimates of between-
group changes in serum cholesterol could be estimated: exercise
versus no treatment (Comparison 01.05). Participants who ex-
ercised did not reduce their serum cholesterol significantly more
than those with no treatment in the three trials, involving 348
participants, that compared the two groups (p=0.65).
Serum triglycerides
There were three groups of trials where pooled estimates of be-
tween-group changes in triglycerides could be estimated: exercise
and diet versus diet alone, high versus low intensity exercise with
dietary change, and exercise versus no treatment (Comparisons
01.06, 03.06 and 04.06). No statistically significant difference be-
tween interventions was observed for exercise and diet versus diet
alone (six trials, 619 participants) (p=0.12) or high versus low in-
tensity exercise with dietary change (two trials, 65 participants)
(p=0.98). Serum triglycerides were reduced by each intervention
and across trials. In the third group of three trials involving 348
participants, people who exercised reduced serum triglycerides by
0.2 mmol/L (95% CI, 0.1 to 0.3) more than those with no treat-
ment (p<0.01).
Serum high-density lipoprotein (HDL)
There was one group of trials where pooled estimates of between-
group changes in serum HDL were able to be estimated: high
versus low intensity exercise with dietary change (Comparison
4.7: Comparisons and Data). Rather than increasing HDL, both
high and low intensity exercise were associated with reduced HDL
across trials. Low intensity exercise was associated with a greater
reduction than high intensity exercise however this difference was
not statistically significant (two trials, 65 participants) (p=0.48).
Fasting serum glucose
There were four groups of trials where pooled estimates of be-
tween-group changes in fasting serum glucose could be estimated:
exercise and diet versus diet alone, high versus low intensity exer-
cise without dietary change, exercise versus no treatment, and ex-
ercise versus diet (Comparisons 01.08, 02.08, 03.08 and 05.06).
Exercise reduced fasting serum glucose by 0.2 mmol/L (95% CI,
0.1 to 0.3) compared with no treatment (two trials, 273 partic-
ipants) (p=0.006). High intensity exercise reduced fasting serum
glucose by 0.3 mmol/L (95% CI, 0.2 to 0.5) more than low inten-
sity exercise (two trials, 46 participants) (p<0.01). When diet and
exercise were compared, diet resulted in an 0.1 mmol/L (95% CI,
0.0 to 0.2) greater reduction in fasting serum glucose than exer-
cise (three trials, 354 participants). However, there was no statis-
tically significant difference between diet and exercise versus diet
in reducing fasting serum glucose (p=0.82). Both interventions
resulted in reduced fasting serum glucose.
Small study bias
Publication bias was examined with the use of a funnel plot. The
funnel plot for weight change (14 studies) did not suggest the
presence of small study bias (Funnel plot).
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Subgroup analyses
The number of trials available for subgroup analysis was limited for
most outcomes except for weight loss in the exercise and diet versus
diet only group of trials. The pooled results from this group of trials
demonstrated a small but statistically significant effect when the
results of a large number of trials were pooled. Subgroup analysis by
sex and age could performed. Analysis by sex did no show relevant
changes in pooled estimates. Analysis by age demonstrated that
the pooled effect for studies with a mean age of participants of
less than 45 years was a reduction in weight of 1.6 kg (95% CI,
0.6 to 2.6) in the exercise and diet group compared with the diet
alone group, and the pooled effect for studies with a mean age of
participants of greater than 45 years was a reduction in weight of
1.0 kg (95%CI, 1.3 to 0.7) in the exercise and diet group compared
with the diet alone group.
Sensitivity analyses
Because most trials reported similar components of quality that
were assessed (method of randomisation, allocation concealment,
and blinding of the assessor), we could not examine the effects of
these variables on outcomes.
D I S C U S S I O N
Summary of findings
The findings of this study demonstrate that exercise has a positive
effect on body weight in people with overweight and obesity. Al-
though exercise alone improved weight loss only marginally com-
pared with no treatment in this study, when combined with di-
etary interventions, the amount of weight loss achieved with ex-
ercise increased substantially. These findings are consistent with
previous reviews (Miller 1997; McTigue 2003; Douketis 2005)
that demonstrate only modest (less than five kg) weight loss with
exercise alone as a weight loss intervention, and improved weight
loss with diet and exercise compared with exercise alone.
An assessment of the effect of exercise intensity on weight loss
was an important part of this study. Numerous trials have shown
that an inverse association between body weight and physical ac-
tivity exists (Coakley 1998; DiPietro 1998; King 2001; Swinburn
2004). However, most of these trials have assessed the effect of
vigorous activity on body weight. The benefits of moderate and
light intensity activity on body weight have been less extensively
evaluated (Stewart 1997; Westerterp 2001; Dionne 2003). There
is some evidence that moderate exercise such as walking, is no more
effective than light exercise, such as calisthenics and stretching, as
part of a weight loss programme (Jakicic 1995; Ross 1996). The
results of this study support the hypothesis that vigorous activity
is more effective than moderate or light intensity exercise in in-
ducing weight loss. In this study high and low intensity exercise
were associated with weight loss, both when combined with di-
etary weight loss methods and when undertaken without dietary
change.
However, high intensity exercise was only significantly better than
low intensity exercise at inducing weight loss when undertaken
without dietary change. When diet was also modified, exercise
intensity did not significantly affect the degree of weight loss. It is
possible that this occurred because when exercise is combined with
diet, the effect of exercise intensity on the magnitude of weight
loss is outweighed by the effects of the dietary intervention.
Diet was demonstrated to be significantly more effective at facil-
itating weight loss than exercise in this meta-analysis. Both low
calorie and low fat diets were used as comparison dietary interven-
tions across clinical trials. Each was more effective at facilitating
weight loss than exercise alone. This is consistent with the find-
ings of other studies that also demonstrate dietary modification
is superior to exercise in attaining weight loss in overweight and
obese adults (Curioni 2005; Hansen 2005). It thus appears that
dietary interventions are a more potent method for creating an
energy imbalance than physical activity interventions.
A strength of this study compared with other systematic reviews
and meta-analyses of exercise and weight loss is the inclusion of
cardiovascular disease (CVD) risk factors as outcome measures for
analyses (Miller 1997; McTigue 2003; Douketis 2005). Positive
effects on CVD risk factors were demonstrated with exercise inter-
ventions in overweight and obese adults in this study. Those who
participated in exercise interventions alone reduced systolic and di-
astolic blood pressure, cholesterol, triglycerides and fasting serum
glucose. They also increased HDL levels. The changes that were
statistically significant compared with no treatment were changes
in diastolic blood pressure, triglycerides, HDL and glucose.
These changes were independent of significant weight loss. Weight
loss does not appear to uniformly improve cardiovascular risk fac-
tors, particularly if 5% or less body weight reduction (Douketis
2005). However, RCTs have demonstrated that exercise improves
risk factors for CVD in adult populations (Campbell 1997; Hu
1999; Hu 2000). The findings of this study indicate that the ben-
efit of exercise on cardiovascular risk factors extends to adults with
overweight and obesity.
Exercise combined with diet also has a positive effect on cardiovas-
cular risk factors. Consistent with previous research, participants
in this study who combined exercise with diet reduced systolic and
diastolic blood pressure, serum cholesterol and triglycerides, and
fasting serum glucose. However, when directly compared, exercise
combined with diet was no more effective in reducing the above
cardiovascular risk factors than diet alone.
The reason for this finding is uncertain. Both diet and physical ac-
tivity are known to improve risk factors for CVD in adults (Ross-
ner 2001; Schubert 2006). It was therefore hypothesized that the
effects of each on CVD risk would be additive and that a com-
bination of both interventions would have greater efficacy than
diet alone. It is possible that participants in the diet only group
also increased physical activity levels as a result of study participa-
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tion. Alternatively, the study may have had insufficient power to
demonstrate an additive effect. The effect of diet was greater than
the effect of exercise on numerous CVD risk factors. Diet may
have therefore masked the effect of exercise on CVD risk factors
between comparison groups.
Both high and low intensity exercise resulted in reduced systolic
blood pressure and serum triglycerides. However, high intensity
exercise had a greater positive effect on fasting serum glucose than
low intensity exercise, suggesting that exercise intensity affects the
magnitude of the health benefit of the exercise undertaken. It
has previously been proposed that a threshold of vigorous activity
volume exists which has to be reached to affect CVD risk in adults
(Cox 2003). Results of this study support this hypothesis and
suggest that this threshold may also exist in overweight and obese
adults.
Limitations of the review
A limitation of this systematic review is the paucity of long-term
trials available for inclusion in the analyses. Most people lose
weight initially and then regain it over time (Egger 1997). Thus,
without longer term trials, the true effect of exercise on body
weight is difficult to determine. Also, without long-term trials,
the effects of exercise on mortality are difficult to determine. The
results of this study demonstrated that exercise was associated with
improvement in CVD risk factors. However, the effect of exer-
cise on disease endpoints such as myocardial infarction, cerebro-
vascular accident and type 2 diabetes could not be demonstrated.
Without long-term trials it is assumed, but not definite, that ex-
ercise will also have positive impacts on these end-points.
Also, a large number of studies were excluded from analysis due
to the relatively large losses to follow-up. This was done because if
studies with large losses to follow-up were included in the analyses,
valid conclusions about the relative efficacy of exercise interven-
tions could not be drawn. Although this is a valid justification to
exclude studies with large losses to follow-up, the negative effect
of doing so is to reduce the power of meta-analyses.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review suggests that exercise is an effective weight loss inter-
vention, particularly when combined with dietary interventions.
Exercise is also an effective intervention for improving a range of
secondary outcomes even when weight loss does not occur. While
this review did not show any long-term morbidity and mortality
benefits associated with exercise, exercise was shown to positively
impact the intermediate outcomes that are commonly associated
with cardiovascular disease.
Implications for research
A large amount of research has been undertaken to assess the ef-
fects of exercise on weight loss in people who are overweight or
obese. Exercise stimuli that have been studied include walking,
jogging, weights training, stationary cycling, aerobics, ball games,
calisthenics and stair stepping. Further studies could assess alter-
native exercise stimuli such as increased incidental physical activity
and water based activities. Every effort should be made to maintain
high retention rates in trials, and reasons for withdrawal should
be ascertained so that factors affecting exercise adherence can be
further explored. Studies with longer duration of follow-up would
provide further information regarding the long-term health effects
of regular physical activity in people who are overweight or obese.
N O T E S
CHANGES TO PUBLISHED PROTOCOL
OBJECTIVE: Changed from ’regular physical activity’ to ’exer-
cise’; add ’overweight’ to ’obesity’
TYPES OF STUDIES: Add ’loss to follow-up of less than 15%’;
delete ’quasi-randomised trials’
TYPES OF OUTCOME MEASURES: Delete from additional
outcome measures ’VO2max’ and ’cost’; delete ’relapse’; timing of
outcome assessment changed to ’duration including follow-up of
three months or more were included’
METHODS OF THE REVIEW: Change second reviewer from
CDM to HCG for quality assessment of trials, data extraction,
data entry; change third reviewer from FT to POR for resolving
differences of opinion
DATA ANALYSIS: Dichotomous data not identified therefore
relative risk omitted; heterogeneity explored using I-squared in
addition to chi-squared
P O T E N T I A L C O N F L I C T O F
I N T E R E S T
None known.
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T A B L E S
Characteristics of included studies
Study Aggel-Leijssen 2001
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 7.5%
Analysis by treatment received
Participants COUNTRY: Netherlands
n: 40
AGE: N=38.9 years
MALES=all
WEIGHT ENTRY CRITERIA: BMI > 27
EXCLUSION CRITERIA: >2 hrs a week spent in sports activities, subjects with physically demanding jobs
Interventions INTERVENTION 1 (n=17): modifast very low calorie diet for 6 weeks then low calorie diet
INTERVENTION 2 (n=20): modifast for 6 weeks then low calorie diet + exercise (cycle ergometer, walking
or aqua jogging) 4 times a week for 60 minutes a session at 40% VO2 max intensity
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, body density
OTHER: VO2 max, physical activity questionnaire
Notes
Allocation concealment B – Unclear
Study Aggel-Leijssen 2001b
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: Netherlands
n: 13
AGE: N=40.7 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 29
EXCLUSION CRITERIA: abnormal menstrual cycle, poor health as assessed by medical history and physical
examination, > 3 kg weight change in the previous 2 months, taking medication known to affect the variables
measured, < 2 hours a week in sports activities, physically demanding employment
Interventions INTERVENTION 1 (n=7): cycle ergometry 3 days a week for 57 minutes at 40% VO2max
INTERVENTION 2 (n=6): no exercise FOLLOW-UP: 12 weeks
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Characteristics of included studies (Continued )
Outcomes BODY MEASURES: weight loss (kg), hydrostatic weighing, WHR, waist circumference
OTHER: VO2 max, indirect calorimetry, U-13C palmitate infusion, 1,2-13C acetate infusion, free fatty
acids, glucose, glycerol, triglycerides, insulin, catecholamines
Notes All upper body obese. Lower body obese participants were not part of a randomised controlled trial. Variance
for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Aggel-Leijssen 2002
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 10%
Analysis by treatment received
Participants COUNTRY: Netherlands
n: 24
AGE: N=43.4 years
MALES=all
WEIGHT ENTRY CRITERIA: BMI > 27
EXCLUSION CRITERIA: poor physical health, use of medication known to influence the variables mea-
sured, > 3 kg body weight change during 2 months before selection, > 2 hours a week in sports activities,
physically demanding job
Interventions INTERVENTION 1 (n=8): cycle ergometry 3 days a week for 33 minutes at 70% VO2max
INTERVENTION 2 (n=8): cycle ergometry 3 days a week for 57 minutes at 40% VO2max
CONTROL (n=8): no intervention FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, hydrostatic weighing
OTHER: VO2 max, U-13C palmitate infusion, 1,2-13C acetate infusion, free fatty acids, glucose, glycerol,
triglycerides
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Anderson 1999
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - yes
DURATION OF INTERVENTION: 16 weeks
DROPOUTS: 2%
Analysis by treatment received
Participants COUNTRY: USA
n: 40
AGE: N=42.9 years
MALES=none
WEIGHT ENTRY CRITERIA: minimum of 15 kg overweight (Metropolitan Life Insurance tables)
EXCLUSION CRITERIA: subjects with bulimia nervosa, binge eating disorder, significant depression,
and other psychiatric disturbances, identified contra indications to diet, exercise or both, including recent
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myocardial infarction, a history of cerebrovascular, kidney, or liver disease, cancer type 1 diabetes mellitus,
pregnancy or use of medications known to affect weight or energy expenditure
Interventions INTERVENTION 1 (n=20): low fat, low calorie diet of 1200 kcal a day + structured aerobic exercise by
step aerobics 3 days a week for 45 minutes a session at intensity of 7 - 8.5 METS with bursts to 10.5 - 11
METS
INTERVENTION 2 (n=20): low fat, low calorie diet as above + instruction to increase levels of moderate
intensity physical activity in their daily life by 30 minutes per day most days of the week FOLLOW-UP: 16
weeks
Outcomes BODY MEASURES: weight loss (kg), DXA body composition
OTHER: treadmill testing, lipids, lipoproteins, mood
Notes
Allocation concealment B – Unclear
Study Anderssen 1996
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 1%
Analysis by treatment received
Participants COUNTRY: Norway
n: 219
AGE: all over 40 years
MALES=not stated
WEIGHT ENTRY CRITERIA: BMI > 24
EXCLUSION CRITERIA: >1 workout per week, diastolic blood pressure outside 86-99 mm Hg, cholesterol
outside 5.2-7.74 mmol / L, HDL > 1.2, fasting triglycerides <1.4
Interventions INTERVENTION 1 (n=54):walk / jog, aerobics or circuit training for 3 days a week at 60-80% maximum
heart rate
INTERVENTION 2 (n=55): low fat diet
INTERVENTION 3 (n=67): low fat diet + exercise regimen as outlined above
CONTROL (n=43): no intervention
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: BMI
OTHER: BP, cholesterol, triglycerides, insulin, glucose, VO2 max, factor VII, total energy intake
Notes No raw scores for weight loss in kilograms provided.
Allocation concealment B – Unclear
Study Balkestein 1999
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 11%
Analysis by treatment received
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Participants COUNTRY: The Netherlands
n: 37
AGE: N=37 years
MALES=all
WEIGHT ENTRY CRITERIA: BMI between 27 and 40
EXCLUSION CRITERIA: levels of physical activity more than 2 hours a week in sports or physically de-
manding labour, diabetes, respiratory disease, cardiovascular disorders other than mild hypertension, medi-
cation use, diet, psychiatric disorders and impairment of ability to exert physical activity
Interventions INTERVENTION 1 (n=18): low calorie liquid formula diet INTERVENTION 2 (n=19): low calorie liquid
formula diet + exercise 4 days a week for 60 minutes a session at 40% of maximum heart rate
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: blood pressure, resting heart rate, vascular compliance
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Cox 1996
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 16 weeks
DROPOUTS: 15%
Analysis by treatment received
Participants COUNTRY: Australia
n: 60
AGE: 20-50 years
MALES=all
WEIGHT ENTRY CRITERIA: 120 - 160 % of ideal body weight
EXCLUSION CRITERIA: cigarette smoking, alcohol consumption > 210 ml/week, weight loss of > 10 kg
in the preceding 12 months, hypertension, history of myocardial infarction, stroke, coronary bypass surgery,
renal or hepatic disease, diabetes mellitus, asthma, musculoskeletal exercise that precludes exercise
Interventions INTERVENTION 1 (n=13): vigorous intensity stationary cycling exercise 3 days a week for 30 minutes at
60-70% maximum heart rate
INTERVENTION 2 (n=17): light exercise by flexibility stretching once a week and stationary cycling against
zero resistance twice a week or slow walking (<2 km in 30 minutes)
FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: dietary compliance, physical fitness assessment, BP, alcohol, biochemistry
Notes
Allocation concealment B – Unclear
Study Cox 2004
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
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DURATION OF INTERVENTION: 16 weeks
DROPOUTS: 15%
Analysis by treatment received
Participants COUNTRY: Australia
n: 51
AGE: 20-50 years
MALES=all
WEIGHT ENTRY CRITERIA: 120-160% of ideal weight for height
EXCLUSION CRITERIA: Weight loss of > 10 kg in the preceding 12 months, greater than two 30-minute
sessions of vigorous exercise per week in the previous 6 months, musculoskeletal injury that precluded
exercise, non-steroidal anti-inflammatory drugs, history of diabetes, asthma or heart, renal or hepatic disease,
blood pressure not 130 - 160 systolic and 80 - 100 diastolic, taking antihypertensive medication, alcohol
consumption > 210 mL/wk.
Interventions INTERVENTION 1 (n=17): normal energy intake + light exercise (flexibility exercises once a week and
stationary cycling against zero resistance twice a week for 30 mins. Every second week subjects substituted
one cycling session for a slow walking session of <=2km in 30 mins) INTERVENTION 2 (n=13): normal
energy intake + vigorous exercise (stationary cycling for 30 mins at 60-70% maximum workload 3 times a
week)
INTERVENTION 3 (n=14): low energy intake + light exercise (reduced daily intake by 1000 - 1500 kcal/d)
INTERVENTION 4 (n=15): low energy intake + vigorous exercise FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (kg), WHR, BMI
OTHER: HbA1c, insulin, glucose, VO2 max, total energy intake, dietary components
Notes
Allocation concealment B – Unclear
Study Gillett 1987
Methods DESIGN: Parallel; Randomisation method by random number table
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 16 weeks
DROPOUTS: 6%
Analysis by treatment received
Participants COUNTRY: USA
n: 38
AGE: N=49 years
MALES=none
WEIGHT ENTRY CRITERIA: mean % body fat 42.5 +/- 7.1%
EXCLUSION CRITERIA: smokers, hypertension, pregnancy, non-sedentary for 6 months prior to the
study, known coronary heart disease
Interventions INTERVENTION 1 (n=20): dance exercise up to 53 minutes a session at 60-80 % of maximum heart rate
INTERVENTION 2 (n=18): commercial aerobics for up to 53 minutes a session at 70-80 % of maximum
heart rate
FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (lb), body fat %
OTHER: muscular endurance, flexibility, VO2 max, cholesterol, triglyceride, glucose, HDL, blood pressure,
resting heart rate
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
20Exercise for overweight or obesity (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of included studies (Continued )
Allocation concealment B – Unclear
Study Gordon 1997
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 13%
Analysis by treatment received
Participants COUNTRY: USA
n: 55
AGE: N=48 years
MALES= 31%
WEIGHT ENTRY CRITERIA: percentage body fat >27%
EXCLUSION CRITERIA: known cardiovascular disease apart from hypertension, > 15 minutes of contin-
uous aerobic exercise > 2 days a week during the previous 3 months, contraindications to maximal exercise
testing, participation in dietary program aimed at weight reduction, consumption of > 3 alcoholic drinks a
day, pregnancy, lactation, current use of antihypertensive medication
Interventions INTERVENTION 1 (n=15):low fat, low calorie diet
INTERVENTION 2 (n=14): aerobic exercise (predominantly walking) 3 to 5 days a week for 30 to 45
minutes at 60-85% of maximum heart rate
INTERVENTION 3 (n=19): diet and exercise as described above
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), skinfold thickness
OTHER: food diary, heart rate monitoring, BP, treadmill testing, maximal oxygen uptake
Notes All subjects had hypertension.
Allocation concealment B – Unclear
Study Hays 2004
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 5%
Analysis by treatment received
Participants COUNTRY: USA
n: 34
AGE: N=66 years
MALES:N = 14
WEIGHT ENTRY CRITERIA: participants stated as overweight (method not stated but BMI, % body fat
and body weight reported)
EXCLUSION CRITERIA: current smoker, > 2 d/wk of structured physical activity, weight unstable in past
6 months (+/- >5 kg), normal OGTT, taking medication known to affect glucose metabolism
Interventions INTERVENTION 1 (n=11):low fat, high carbohydrate diet (providing 150% of predicted energy require-
ments) + exercise training 4 days a week on cycle ergometer at 80% to 85% of maximal heart rate for 45
mins
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INTERVENTION 2 (n=11): low fat, high carbohydrate diet
INTERVENTION 3 (n=12): control
FOLLOW-UP: 14 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, % body fat (BOD POD)
OTHER: macronutrient intake, reported physical activity, maximal aerobic capacity, resting energy expen-
diture, resting respiratory exchange ratio, change in fat and lean tissue cross-sectional area of the thigh
Notes
Allocation concealment B – Unclear
Study Hellenius 1993
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 26 weeks
DROPOUTS: 1%
Analysis by treatment received
Participants COUNTRY: USA
n: 157
AGE: N=46.2 years
MALES= all
WEIGHT ENTRY CRITERIA: mean BMI = 25.3
EXCLUSION CRITERIA: poor general health, history of cardiovascular disease, diabetes, regular use of
medications, serum cholesterol not between 5.2-7.8 mmol/L, fasting triglycerides >5.6 mmol/L, fasting blood
glucose >6.7 mmol/L, diastolic blood pressure > 100 mmHg
Interventions INTERVENTION 1 (n=40): low fat, low calorie diet
INTERVENTION 2 (n=39): walk / jog 2-3 days a week at 60-80% of maximum heart rate for 30-45
minutes
INTERVENTION 3 (n=39): diet and exercise as described above
CONTROL (n=39): no intervention
FOLLOW-UP: 26 weeks
Outcomes BODY MEASURES: BMI, waist circumference, WHR
OTHER: food diary, blood pressure, serum cholesterol and triglycerides
Notes
Allocation concealment B – Unclear
Study Irwin 2003
Methods DESIGN: Parallel; Randomisation method by random number generation
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - for DXA scans
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 2%
Analysis by intention to treat
Participants COUNTRY: USA
n: 173
AGE: 50 - 75 years
MALES= none
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WEIGHT ENTRY CRITERIA: BMI >= 24 and >33% body fat
EXCLUSION CRITERIA: non- postmenopausal, non-sedentary (>60 mins / wk of moderate and vigorous
intensity recreational activity and maximal oxygen consumption > 25 mL/kg/min, taking hormone replace-
ment therapy, diabetes, smokers
Interventions INTERVENTION (n=87): 45 mins of moderate intensity exercise 5 d/wk for 12 months (aim 60 - 75%
MHR for 45 mins per session).
CONTROL (n=86): weekly 45-minute stretching sessions for 1 year
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight, height, waist and hip circumference, DXA total body fat and body fat %, CT
intra- abdominal and subcutaneous fat
OTHER: food frequency questionnaire, Minnesota Physical Activity Questionnaire, VO2 max
Notes
Allocation concealment B – Unclear
Study Jakicic 1995
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 20 weeks
DROPOUTS: 15%
Analysis by treatment received
Participants COUNTRY: USA
n: 38
AGE: N=40.6 years
MALES=none
WEIGHT ENTRY CRITERIA: 120- 175% of ideal body weight (Metropolitan Life Insurance tables)
EXCLUSION CRITERIA: medical problems that prevent participation in regular exercise & / or calorie
restricted diet, medication which affects heart rate response to exercise
Interventions INTERVENTION 1 (n=25): low fat, low calorie diet (1200 - 1500 kcal / day) + discussion of behavioral
strategies to modify diet and exercise + short bout exercise (multiple 10 minute bouts of exercise to a total of
20-40 minutes) 5 days a week at 70% maximum heart rate
INTERVENTION 2 (n=27): low fat, low calorie diet (1200 - 1500 kcal / day) + discussion of behavioral
strategies to modify diet and exercise + long bout exercise (single 20-40 minute bout of exercise) 5 days a
week at 70% maximum heart rate FOLLOW-UP: 20 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: exercise participation, food frequency questionnaires, accelerometer data, cardiorespiratory fitness,
resting heart rate, BP
Notes
Allocation concealment B – Unclear
Study Jakicic 2003
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
23Exercise for overweight or obesity (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of included studies (Continued )
DROPOUTS: 6%
Analysis by intention to treat
Participants COUNTRY: USA
n: 201
AGE: N=37 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI 27 to 40
EXCLUSION CRITERIA: exercise > 3 days per week for > 20 mins / d in the previous 6 months, history
of myocardial infarction, taking medication that would alter heart rate response during exercise or affect
metabolism or weight loss, treatment for psychological conditions, currently pregnant, pregnant within the
previous 6 months, planning to become pregnant during the intervention period, any medical condition
that could affect metabolism or body weight or limit exercise participation
Interventions INTERVENTION 1 (n=50): vigorous intensity high duration exercise (5 days a week of brisk walking to
expend 2000 kcal / week)
INTERVENTION 2 (n=50): moderate intensity high duration exercise (5 days a week of slower walking to
expend 2000 kcal / week)
INTERVENTION 3 (n=50): moderate intensity moderate duration exercise (5 days a week of slower walking
to expend 1000 kcal / week)
INTERVENTION 4 (n=51): vigorous intensity moderate duration exercise (5 days a week of brisk walking
to expend 1000 kcal / week)
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: exercise participation, food frequency questionnaires, cardiorespiratory fitness, heart rate per ex-
ercise session, exercise duration, time to achieve 85% of maximal heart rate
Notes
Allocation concealment B – Unclear
Study Janssen 2002
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 16 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: Canada
n: 38
AGE: N=40.1 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 27 and WHR > 0.85
EXCLUSION CRITERIA: unstable weight in the 6 months prior to the study, taking medications, con-
suming greater than 2 standard alcoholic drinks a day, not premenopausal, irregular menstrual cycle
Interventions INTERVENTION 1 (n=11): low calorie diet + aerobic exercise (treadmill walking, exercise bicycle or stair
stepper) 5 days a week for 60 minutes to 50-85% of maximum heart rate
INTERVENTION 2 (n=14): low calorie diet + resistance training (weights machine 3 days a week for 30
minutes a session until 120 kcal expended)
INTERVENTION 3 (n=13): low calorie diet only
FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (kg), % body fat, MRI body fat, WHR, waist circumference
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OTHER: glucose, insulin, glucose tolerance test, serum cholesterol, diet record
Notes
Allocation concealment B – Unclear
Study Jeffery 1998
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 26 weeks
DROPOUTS: 13%
Analysis by treatment received
Participants COUNTRY: USA
n: 193
AGE: N=41 years
MALES=15%
WEIGHT ENTRY CRITERIA: between 14 and 32 kg overweight according to actuarial norms
EXCLUSION CRITERIA: serious medical complaints, unable to walk for exercise, unwilling to be random-
ized to treatment conditions
Interventions INTERVENTION 1 (n=40): standard behaviour therapy
INTERVENTION 2 (n=41): standard behaviour therapy + supervised walks 3 days a week
INTERVENTION 3 (n=42): standard behaviour therapy + supervised walks 3 days a week with personal
trainer+ reminders from personal trainer
INTERVENTION 4 (n=37): standard behaviour therapy + supervised walks with a personal trainer + money
INTERVENTION 5 (n=36): standard behaviour therapy + supervised walks with a personal trainer +
reminders + money
FOLLOW-UP: 26 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: physical activity questionnaire, food frequency questionnaire, Beck depression inventory, binge
eating questionnaire, barriers to adherence questionnaire
Notes
Allocation concealment B – Unclear
Study Jeffery 2003
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 78 weeks
DROPOUTS: 13% at 6 months
Analysis by treatment received
Participants COUNTRY: USA
n: 202
AGE: N=42.2 years
MALES=42%
WEIGHT ENTRY CRITERIA: between 14 and 32 kg overweight according to actuarial norms
EXCLUSION CRITERIA: serious medical or psychological problems thought to interfere with treatment,
not aged between 25 - 50 years
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Interventions INTERVENTION 1 (n=82): standard behaviour therapy
INTERVENTION 2 (n=100): standard behaviour therapy + physical activity (energy expenditure equivalent
of 2500 kcal/wk)
FOLLOW-UP: 26 weeks (dropout rate > 15% at 52 and 78 weeks)
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: Paffenbarger Physical Activity Questionnaire, Block diet questionnaire
Notes
Allocation concealment B – Unclear
Study Kiernan 2001
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 13%
Analysis by treatment received
Participants COUNTRY: USA
n: 119
AGE: N=38.5 years
MALES=50%
WEIGHT ENTRY CRITERIA: BMI of 28 to 34 (males) and 24 to 30 (females)
EXCLUSION CRITERIA: smokers, non sedentary, poor health, use of blood pressure or lipid lowering
medication, postmenopausal women
Interventions INTERVENTION 1 (n=81): low fat diet + exercise by brisk walking / jogging 3 days a week for 45 minutes
a session to intensity of 60- 80% of maximum heart rate
INTERVENTION 2 (n=71): low fat diet only
CONTROL (n=79): waiting list control
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: VO2 max, eating inventory, depression inventory, aerobic capacity
Notes
Allocation concealment B – Unclear
Study Leutholtz 1995
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 0%
Analysis by treatment received
Participants COUNTRY: USA
n: 40
AGE: N=41 years
MALES=18%
WEIGHT ENTRY CRITERIA: body fat % > 25% for men and > 30% for women
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EXCLUSION CRITERIA: coronary or peripheral atherosclerosis, ketosis prone diabetes mellitus, chronic
use of steroids, bleeding peptic ulcer, history of suicide attempts, active thrombophlebitis, alcohol abuse,
pregnancy, lactation, inability to exercise, use of beta blockers or other exercise limiting medications
Interventions INTERVENTION 1 (n=20): liquid formula Optifast diet (420 kcal / day) + exercise by walking at a target
heart rate of 60% of maximum heart rate to a distance that expended 300 kcal of energy
INTERVENTION 2 (n=20): liquid formula Optifast diet (420 kcal / day) + exercise by walking at a target
heart rate of 40% of maximum heart rate to a distance that expended 300 kcal of energy
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), lean body mass, fat mass
OTHER: resting heart rate, BP, VO2 max
Notes
Allocation concealment B – Unclear
Study Manning 1991
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 9%
Analysis by treatment received
Participants COUNTRY: USA
n: 24
AGE: 22-57 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 30
EXCLUSION CRITERIA: physical activity in the previous 6 months, unstable weight in the previous 6
months
Interventions INTERVENTION (n=40): strength training with weights 3 days a week for 12 weeks to 60-70% of maximum
heart rate
CONTROL (n=6): no intervention
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: dietary record, LDL, HDL, cholesterol, triglycerides, apolipoproteins
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Neumark 1995
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 5%
Analysis by treatment received
Participants COUNTRY: Israel
n: 42
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AGE: 25-50 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 27
EXCLUSION CRITERIA: health problems, lack of interest in participation
Interventions INTERVENTION (n=19): low calorie diet (<1000 kcal) + self monitoring
INTERVENTION 2 (n=21): diet + self monitoring as above + supervised aerobic exercise for 1 hour per
week + 15 minutes of walking / jogging 5 days a week + 10 minutes of other unspecified exercise 6 days a
week
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), skinfold thicknesses, WHR, waist circumference, BMI
OTHER: exercise compliance, physical fitness
Notes
Allocation concealment B – Unclear
Study Nieman 1998
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 11%
Analysis by treatment received
Participants COUNTRY: USA
n: 91
AGE: N=45.6 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI between 25 and 65
EXCLUSION CRITERIA: serious medical complaints, unable to walk for exercise, unwilling to be random-
ized to treatment conditions
Interventions INTERVENTION 1 (n=21): 45 minutes of walking 5 days a week at 60-75% maximum heart rate INTER-
VENTION 2 (n=26): 1200 - 1300 kcal a day diet
INTERVENTION 3 (n=22): low calorie diet and exercise as outlined above
INTERVENTION 4 (n=22): no treatment control
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), body composition, body fat %
OTHER: adaptive immunity, natural killer cell activity, phagocytosis and oxidative burst, aerobic power,
VO2 max, glucose, triglycerides, cholesterol, maximum heart rate
Notes Variance for change in weight with exercise only and control interventions not reported therefore results
reported narratively only.
Allocation concealment B – Unclear
Study Pritchard 1997
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
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DROPOUTS: 12%
Analysis by treatment received
Participants COUNTRY: Australia
n: 39
AGE: N=43.4 years
MALES=all
WEIGHT ENTRY CRITERIA: mean BMI 29 +/- 2.6
EXCLUSION CRITERIA: inability to satisfactorily complete standardized fitness test
Interventions INTERVENTION 1 (n=21): 3 sessions of 30 minutes a week of aerobic exercise of the participants choice
to an intensity of 65-75% of maximum heart rate
INTERVENTION 2 (n=18): low fat diet
FOLLOW-UP: 52 weeks
Outcomes MEASURES: weight loss (kg), waist circumference, WHR, body composition (DXA)
OTHER: 24 hour food recall, 3 day food diary, activity log
Notes
Allocation concealment B – Unclear
Study Raz 1994
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: Israel
n: 40
AGE: N=56.6 years
MALES=35%
WEIGHT ENTRY CRITERIA: BMI > 25
EXCLUSION CRITERIA: Ischaemic heart disease, systolic hypertension, inability to use a bicycle ergometer,
unwillingness to accept control group treatment assignment
Interventions INTERVENTION (n=19): 45 mins of cycle ergometry, treadmill and or rowing machine to 65% of VO2
max for 3 days a week
CONTROL (n=19): no change to lifestyle
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: glucose, fructosamine, HbA1c, cholesterol, HDL, triglycerides, resting heart rate, maximal work
capacity
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Ross 1996
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
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DURATION OF INTERVENTION: 16 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: Canada
n: 33
AGE: N=44.5 years
MALES=all
WEIGHT ENTRY CRITERIA: BMI > 27
EXCLUSION CRITERIA: change in weight of more than 2 kg in the previous 6 months, taking medication
known to affect the study variables, consumption of > 2 alcoholic beverages daily
Interventions INTERVENTION 1 (n=11): low calorie diet (1000 kcal / d)
INTERVENTION 2 (n=11): low calorie diet as above + aerobic exercise by bicycling / walking / stair stepping
5 days a week for 60 minutes a session
INTERVENTION 3 (n=11): low calorie diet as outlined above + resistance exercise using a weights machine
3 days a week with 8-12 repetitions per session to a calculated energy expenditure of 120 kcal per session
FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (kg), waist circumference, WHR, regional adipose tissue distribution (MRI)
OTHER: VO2 max, strength-training performance, dietary records
Notes All subjects had upper body obesity
Allocation concealment B – Unclear
Study Schwartz 1987
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: USA
n: 26
AGE: N=31.4 years
MALES=all
WEIGHT ENTRY CRITERIA: 110-185% of ideal body weight (Metropolitan Life Insurance tables)
EXCLUSION CRITERIA: poor health, unstable weight, cigarette smoking, use of prescription or over the
counter medications, participation in regular exercise
Interventions INTERVENTION 1 (n=12): low calorie diet (1200 kcal / d)
INTERVENTION 2 (n=14): brisk walking / jogging 3 days a week for 40 minutes a session at 70-85%
maximum heart rate
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), body fat %
OTHER: lipoproteins, total and fractionated cholesterol, VO2 max
Notes
Allocation concealment B – Unclear
Study Schwartz 1990
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
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patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 9%
Analysis by treatment received
Participants COUNTRY: USA
n: 31
AGE: N=30.9 years
MALES=all
WEIGHT ENTRY CRITERIA: mean body fat % of groups was 28.4% for the diet group and 30.1% for
the exercise group
EXCLUSION CRITERIA: poor health, unstable weight, cigarette smoking, participation in a regular exercise
program, use of prescribed or over the counter medications
Interventions INTERVENTION 1 (n=13): low calorie diet (1200 kcal / d)
INTERVENTION 2 (n=18): brisk walking / jogging 3 days a week for 40 minutes a session at 70-85% of
maximum heart rate
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), body fat mass, % body fat
OTHER: food diary, plasma epinephrine and norepinephrine clearance, baseline pulse rate
Notes
Allocation concealment B – Unclear
Study Stefanick 1998
Methods DESIGN: Factorial; Randomisation by computer - the Efron method
BLINDING:
patients - no
caregivers - no
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 3%
Analysis by treatment received
Participants COUNTRY: USA
n: 377
AGE: 30-64 years
MALES=52%
WEIGHT ENTRY CRITERIA: not stated - WHR for men > 0.94 and women > 0.82
EXCLUSION CRITERIA: elevated HDL levels, history of heart disease, stroke, diabetes, recent cancer,
other life-threatening illnesses or any condition limiting their ability to engage in moderate exercise, taking
insulin or heart medications, blood pressure or high serum cholesterol, smoking more than 9 cigarettes daily,
consuming more than 4 alcoholic drinks a day
Interventions INTERVENTION 1 (n= 43): supervised aerobic exercise equivalent to brisk walking or jogging 3 days per
week for 60 minutes per session
INTERVENTION 2 (n=46): low fat diet
INTERVENTION 3 (n=43): diet and exercise as outlined above CONTROL (n= 45): no change to diet or
exercise
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg), WHR
OTHER: cholesterol, triglycerides, HDL, LDL, glucose, BP, VO2max
Notes
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Allocation concealment B – Unclear
Study Stensel 1994
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - no
caregivers - no
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 10%
Analysis by treatment received
Participants COUNTRY: UK
n: 72
AGE: 42-59 years
MALES=all
WEIGHT ENTRY CRITERIA: not stated - BMI was > 25.2 for participants
EXCLUSION CRITERIA: non-sedentary, employed in a strenuous job
Interventions INTERVENTION 1 (n= 48): walking up to 40-45 minutes a day a minimum of 3 days a week
CONTROL (n= 24): no change to diet or exercise
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, WHR, body density, % body fat
OTHER: VO2 max, blood lactate, dietary intake
Notes Variance for change in weight with interventions not reported therefore results reported narratively only
Allocation concealment B – Unclear
Study Svendsen 1993
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 3%
Analysis by treatment received
Participants COUNTRY: Denmark
n: 121
AGE: N=53.8 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 25
EXCLUSION CRITERIA: menstrual bleeding in the preceding 6 months, hysterectomy, weight loss in
the preceding 3 months, lack of motivation or ability to participate, psychiatric illness, cardiovascular, pul-
monary, catabolic, renal or hepatic disease, medication known to influence body composition, hormones,
antihistamines and catabolic drugs
Interventions INTERVENTION 1 (n=51): diet only (formula diet providing 1.6 MJ daily) INTERVENTION 2 (n=49):
supervised aerobic exercise and resistance weights training 3 days a week for 60 - 90 minutes per session at
70% VO2 max intensity + diet as outlined above
CONTROL (n= 21): no change to diet or exercise
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), body composition, bone mineral density, fat tissue and lean tissue
mass, skinfold thicknesses, WHR
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OTHER: blood pressure, pulse, food diaries, HDL, cholesterol, triglycerides, alkaline phosphatase
Notes
Allocation concealment B – Unclear
Study Thong 2000
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: Canada
n: 52
AGE: N=44.4 years
MALES=all
WEIGHT ENTRY CRITERIA: BMI > 30
EXCLUSION CRITERIA: none stated
Interventions INTERVENTION 1 (n=14): low calorie diet INTERVENTION 2 (n=14): brisk walking or jogging on a
motorized treadmill daily for 12 weeks at intensity up to but not exceeding 75% of maximum heart rate
CONTROL (n= 8): no change to diet or exercise
FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, waist circumference, WHR, MRI fat stores
OTHER: VO2 max, leptin levels
Notes
Allocation concealment B – Unclear
Study Utter 2000
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: 4%
Analysis by treatment received
Participants COUNTRY: USA
n: 27
AGE: N=42.3 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI between 25-34
EXCLUSION CRITERIA: physically active > 3 moderate to vigorous aerobic sessions of greater than 20 mins
duration per week, poor health, diabetes, cancer, heart disease, cigarette smoking, history of gastrointestinal
disease, gallstones, gallbladder sludge or other pathology of the gallbladder, currently on weight reduction
diet, weight loss of > 5% in the previous 3 months
Interventions INTERVENTION 1 (n=16): walking 5 days a week, 45 mins a session to intensity of 60-80 % of maximum
heart rate
CONTROL (n= 11): no change to diet or exercise
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FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI, body fat %
OTHER: gallbladder emptying, VO2 max, energy intake, treadmill time, BP, VO2 max
Notes Variance for change in weight with interventions not reported therefore results reported narratively only.
Allocation concealment B – Unclear
Study Wadden 1997
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 24 weeks
DROPOUTS: 12%
Analysis by treatment received
Participants COUNTRY: USA
n: 120
AGE: N=41.1 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI > 30
EXCLUSION CRITERIA: bulimia nervosa, significant depression, other major psychiatric disorders, recent
myocardial infarction, cerebrovascular, kidney or liver disease, cancer, type 1 diabetes, pregnancy, use of
medications known to affect weight and energy expenditure
Interventions INTERVENTION 1 (n=29): low calorie diet (900 kcal / d including liquid formula diet )
INTERVENTION 2 (n=31): diet as above + step aerobics 3 days a week for 50-55 minutes a session at
intensity of 11-15 on Borgs Rating of Perceived Exertion Scale
INTERVENTION 3 (n=31): diet as above + strength training using fixed weights 3 days a week for 10-14
repetitions up to 40 minutes duration
INTERVENTION 4 (n=29): diet as above + aerobic training as above + strength training as above
FOLLOW-UP: 24 weeks
Outcomes BODY MEASURES: weight loss (kg), body densitometry, % body fat, fat free mass
OTHER: indirect calorimetry, food cravings/ hunger/ satiety/ preoccupation measures, Beck Depression
Inventory and mood questionnaire, resting energy expenditure
Notes
Allocation concealment B – Unclear
Study Wallace 1997
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 14 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: USA
n: 16
AGE: N=41.2 years
MALES=all
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WEIGHT ENTRY CRITERIA: WHR>1.02
EXCLUSION CRITERIA: non- hyper insulinaemic, non-sedentary, non- dyslipidaemic, normotensive
Interventions INTERVENTION 1 (n=8): 60 mins of aerobic exercise (30 minutes each of cycle ergometry and treadmill
walking) at 60-70 % maximum heart rate for 3 days a week
INTERVENTION 2 (n=8): endurance training as above + resistance weights for 8-12 sets at intensity of
75% 1RM
FOLLOW-UP: 14 weeks
Outcomes BODY MEASURES: weight loss (kg), % body fat, WHR, body composition
OTHER: electrolytes strength testing
Notes
Allocation concealment B – Unclear
Study Whatley 1994
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 12 weeks
DROPOUTS: none
Analysis by treatment received
Participants COUNTRY: USA
n: 23
AGE: N=38.5 years
MALES=none
WEIGHT ENTRY CRITERIA: BMI between 30 and 42
EXCLUSION CRITERIA: significant medical illness, unstable weight or participation in weight loss activities
in the previous 6 months
Interventions INTERVENTION 1 (n=7): very low energy liquid formula diet
INTERVENTION 2 (n=8): very low energy liquid formula diet + walking and weights training 3 days a
week at 50-65% of maximum heart rate
INTERVENTION 3 (n=8): very low energy liquid formula diet + walking 5 days a week and weights training
3 days a week at 50-65% of maximum heart rate FOLLOW-UP: 12 weeks
Outcomes BODY MEASURES: weight loss (kg), % body fat, WHR
OTHER: VO2 max, resting metabolic rate
Notes
Allocation concealment B – Unclear
Study Wing 1988
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - no
caregivers - no
outcome assessors - yes
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 7%
Analysis by treatment received
Participants COUNTRY: USA
n: 30
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AGE: N=55.6 years
MALES=not stated
WEIGHT ENTRY CRITERIA: >120 % of ideal body weight
EXCLUSION CRITERIA: non- diabetic, not aged between 30 and 65 years, history of coronary heart
disease, taking medications which could interfere with weight loss or heart rate during exercise, orthopaedic
problems that would limit walking
Interventions INTERVENTION 1 (n=15): walking 3 miles four days a week + low calorie diet calculated to produce 1 kg
/ wk weight loss
INTERVENTION 2 (n=15): low calorie diet only
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg), BMI
OTHER: HbA1c, cholesterol, triglycerides, BP, glucose, insulin
Notes All type 2 diabetes. Variance for change in weight with interventions not reported therefore results reported
narratively only.
Allocation concealment B – Unclear
Study Wing 1998
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 26 weeks
DROPOUTS: 15%
Analysis by treatment received
Participants COUNTRY: USA
n: 154
AGE: N=45.7 years
MALES=21%
WEIGHT ENTRY CRITERIA: 130 - 200% of ideal body weight
EXCLUSION CRITERIA: diabetics, no family history of diabetes
Interventions INTERVENTION 1 (n=37): walking for 50-60 minutes up to 5 days a week to expend 1500 kcal a week
INTERVENTION 2 (n=37): low calorie, low fat diet
INTERVENTION 3 (n=40): low fat, low calorie diet + aerobic exercise as outlined above
CONTROL (n=40): given self-help behavioral manual with information on healthy eating, exercise and
behavioral strategies for weight control
FOLLOW-UP: 26 weeks
Outcomes BODY MEASURES: weight loss (kg), waist circumference, WHR
OTHER: glucose tolerance test, insulin, fasting glucose, HbA1c, cholesterol and triglycerides, HDL, blood
pressure, physical activity assessment, food frequency measures
Notes All subjects had a family history of non-insulin dependent diabetes mellitus.
Allocation concealment B – Unclear
Study Wirth 1985
Methods DESIGN: Parallel; Randomisation method not stated
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - not stated
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DURATION OF INTERVENTION: 16 weeks
DROPOUTS: 7%
Analysis by treatment received
Participants COUNTRY: Germany
n: 21
AGE: N=43 years
MALES=all
WEIGHT ENTRY CRITERIA: not stated - mean body fat % = 24
EXCLUSION CRITERIA: no hyper triglyceridaemia
Interventions INTERVENTION 1 (n=10): jogging, ball games and calisthenics 3 times a week for 1 hour to achieve a
pulse between 120 and 150 beats per minute
CONTROL (n=11): no treatment
FOLLOW-UP: 16 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: cholesterol, LDL, HDL, apo lipoprotein A1, insulin, blood pressure, body fat %, energy expendi-
ture, glycerol release
Notes All patients had hyper triglyceridaemia. Variance for change in weight with interventions not reported
therefore results reported narratively only.
Allocation concealment B – Unclear
Study Wood 1988
Methods DESIGN: Parallel; Randomisation method by envelopes
BLINDING:
patients - not stated
caregivers - not stated
outcome assessors - unclear
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 15%
Analysis by treatment received
Participants COUNTRY: USA
n: 131
AGE: N=44.6 years
MALES=all
WEIGHT ENTRY CRITERIA: 120-160 % of ideal body weight
EXCLUSION CRITERIA: smokers, consumed more than four alcoholic drinks per day, taking medications
affecting blood pressure or lipids, were not expected to remain living in the local area for 12 months
Interventions EXERCISE INTERVENTION (n=47): jogging 60-80% of maximum heart rate for 40 to 50 minutes at
least 3 days a week
DIET INTERVENTION (n=42): low fat diet
CONTROL (n=42): waiting list
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: serum cholesterol and triglycerides, LDL and HDL
Notes
Allocation concealment B – Unclear
Study Wood 1991
Methods DESIGN: Factorial; Randomisation method not stated
BLINDING:
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patients - not stated
caregivers - not stated
outcome assessors - not stated
DURATION OF INTERVENTION: 52 weeks
DROPOUTS: 12.5%
Analysis by treatment received
Participants COUNTRY: USA
n: 231
AGE: 25-49 years
MALES=50%
WEIGHT ENTRY CRITERIA: 120-150% of ideal body weight
EXCLUSION CRITERIA: smokers, non sedentary, consumed four or more alcoholic drinks per day, poor
physical health, taking medications known to affect blood pressure or lipid metabolism, pregnancy, lactation,
use of oral contraceptives, blood pressure over 160/95 at rest, plasma total cholesterol above 6.72 mmol per
liter, plasma triglycerides above 5.65 mmol per liter
Interventions INTERVENTION 1 (n=81): brisk walking / jogging for 40 to 50 minutes at least 3 days a week + low fat /
low calorie diet
INTERVENTION 2 (n=71): low calorie, low fat diet
CONTROL (n=79): waiting list
FOLLOW-UP: 52 weeks
Outcomes BODY MEASURES: weight loss (kg)
OTHER: serum cholesterol and triglycerides, LDL and HDL, blood pressure
Notes
Allocation concealment B – Unclear
n=number of subjects; N=mean; kg=kilograms; BMI=body mass index; HDL=high-density lipoprotein; LDL=low-density lipoprotein; BP=blood
pressure; HbA1c=glycosylated haemoglobin; WHR=waist-to-hip ratio; RCT = randomised controlled trial.
Characteristics of excluded studies
Study Reason for exclusion
Ades 2003 Participants not overweight or obese
Aiello 2004 No weight loss data for controls
Aldred 1995 Participants not overweight or obese
Asikainen 2002 Participants not overweight or obese
Blumenthal 2000 Loss to follow-up of greater than 15%
Cox 2003 Loss to follow-up of greater than 15%
Cuff 2003 Initial sample size not specified - only the number who completed the study
Donnelly 2003 Loss to follow-up of greater than 15%
Dunn 1999 Loss to follow-up of greater than 15%
Dzator 2004 Loss to follow-up of greater than 15%
Esposito 2003 Loss to follow-up of greater than 15%
Esposito 2004 Diet + exercise versus no treatment control
Figueroa 2003 Participants not all overweight or obese
Fogelholm 2001 Weight maintenance study
Grant 2004 Loss to follow-up of greater than 15%
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Hartwell 1986 Numbers in each intervention group not given
Hinderliter 2002 Loss to follow-up of greater than 15%
Houmard 2003 Loss to follow-up of greater than 15%
Huttunen 1979 Weight loss discouraged whilst dieting and exercising
Jakicic 1998 Unable to extract mean and standard deviation data for primary or secondary outcomes
Kirk 2003 Loss to follow-up of greater than 15%
Kraemer 1997 Unable to extract mean and standard deviation data for primary or secondary outcomes
Kraemer 1999 Loss to follow-up of greater than 15%
Lehmann 1995 Not randomized controlled clinical trial
Lejeune 2003 Loss to follow-up of greater than 15%
Levesque 1997 Participants not overweight or obese
Lindstrom 2003 Loss to follow-up of greater than 15%
Loreto 2003 Participants not all overweight or obese
Mensink 2003 Loss to follow-up of greater than 15%
Messier 2000 Unable to extract mean and standard deviation data for primary or secondary outcomes
Nicklas 2004 Loss to follow-up of greater than 15%
Okura 2003 Non-random allocation to groups
Potteiger 2003 Loss to follow-up of greater than 15%
Probart 1991 Participants not overweight or obese
Proper 2003 Loss to follow-up of greater than 15%
Racette 1995 Loss to follow-up of greater than 15%
Ribeiro 1984 Not randomized controlled clinical trial or pretest-intervention-post test design
Samaras 1997 No exercise prescription
Schmitz 2003 Participants not all overweight or obese
Schuler 1991 Participants not overweight or obese
Slentz 2004 Loss to follow-up of greater than 15%
Stahle 2000 Participants not overweight or obese
Teixeira 2003 Participants not overweight or obese
Watkins 2003 Loss to follow-up of greater than 15%
Weinstock 1998 Unable to extract mean and standard deviation data for primary or secondary outcomes
Yamanouchi 1995 Intervention < 12 weeks duration
RCT = randomised controlled trial
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A D D I T I O N A L T A B L E S
Table 01. Search Strategy
Search terms
The following Medline search strategy was used and adapted for use with the other databases.
NOTES: unless stated otherwise, search terms are free text terms; MeSH: Medical subject heading (Medline medical index term); an
asterisk (*) stands for ’any character(s)’, a question mark stands for ’one or no character’.
OBESITY OR WEIGHT LOSS
1 Obesity/ [MeSH term, all sub trees and subheadings included]
2 Bulimia/ [MeSH term, all subheadings included]
3 Hyperphagia/ [MeSH term, all subheadings included]
4 Anti-Obesity-Agents/ [MeSH term, all subheadings included]
5 Pickwickian syndrome (and) Prader-Willi-syndrome/[MeSH term, all subheadings included]
6 (obes* or adipos* or overweight* or over weight*) [in abstract or title]
7 (overeat* or overfeed*) [in abstract or title]
8 (binge eating disorder* or fat overload syndrom*) [in abstract or title]
9 Weight-gain/ [MeSH term, all subheadings included]
10 Weight-loss/ [MeSH term, all subheadings included]
11 Body-Mass-Index/ [MeSH term]
12 weight gain [in abstract or title]
13 weight cycling [in abstract or title]
14 (weight near (reduc* or loss losing or maint* or decreas* or watch* or diet* or control*)) [in abstract or title]
15 or/1-14
This was combined with the following search strategy:
EXERCISE
1. exercis* OR (physic* activ*) OR exert* OR (physic* fit*) OR sports (text words)
2. walk* or jog* or swim* (text words)
3. (weight lift*) OR (strength train*) OR (resistance train*) OR (circuit weight train*) OR (aerob* train*) (text words)
4. exercise/ [MeSH term, all subheadings and categories included]
5. exertion/ [MeSH term, all subheadings and categories included]
6. physical education/ [MeSH term, all subheadings and categories included]
7. training/ [MeSH term, all subheadings and categories included]
8. physical-fitness/ [MeSH term, all subheadings and categories included]
9. sports/ [MeSH term, all subheadings and categories included]
10. OR/ 1-9
This was combined with the following search strategy:
RANDOMISED CONTROLLED TRIALS
1 RANDOMISED-CONTROLLED-TRIAL in PT
2 “RANDOMISED-CONTROLLED-TRIALS”/ all subheadings
3 “RANDOM-ALLOCATION” in MIME, MJME
4 random* or alloc* or assign*
5 (#4 in TI) or (#4 in AB)
6 #1 or #2 or #3 or #5
7 CONTROLLED-CLINICAL-TRIAL in PT
8 CLINICAL-TRIAL in PT
9 explode “CLINICAL-TRIALS”/ all subheadings
10 (CLIN* near TRIAL*)
11 (#10 in TI) or (#10 in AB)
12 “CROSS-OVER-STUDIES” in MIME, MJME
13 cross-over near (stud* or trial* or design*)
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Search terms
14 crossover near (stud* or trial* or design*)
15 #7 or #8 or #9 or #11 or #12 or #13 or 14
16 “DOUBLE-BLIND-METHOD” in MIME, MJME
17 “SINGLE-BLIND-METHOD” in MIME, MJME
18 (singl* or doubl* or trebl* or tripl*) near (blind* or mask*)
19 (#18 in TI) or (#18 in AB)
20 #16 or #17 or #19
21 “PLACEBOS”/ all subheadings
22 placebo* in TI
23 placebo* in AB
24 #21 or #22 or #23
25 explode “RESEARCH-DESIGN”/ all subheadings
26 TG=COMPARATIVE-STUDY
27 explode “EVALUATION-STUDIES”/ all subheadings
28 “FOLLOW-UP-STUDIES” in MIME, MJME
29 “PROSPECTIVE-STUDIES” in MIME, MJME
30 control* or prospectiv* or volunteer*
31 (#30 in TI) or (#30 in AB)
32 #25 or #26 or #27 or #28 or #29 or #31
33 #6 or #15 or #20 or #24 or #32
34 (TG=ANIMAL) not ((TG=HUMAN) and (TG=ANIMAL))
35 #33 not #34
This was combined with the following search strategy:
SYSTEMATIC REVIEWS AND META-ANALYSES
1 “META-ANALYSIS” in MIME,MJME
2 explode “REVIEW-LITERATURE”/ all subheadings
3 META-ANALYSIS in PT
4 REVIEW in PT
5 REVIEW-ACADEMIC in PT
6 REVIEW-LITERATURE in PT
7 REVIEW-TUTORIAL in PT
8 GUIDELINE in PT
9 PRACTICE-GUIDELINE in PT
10 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9
11 REVIEW-OF-REPORTED-CASES in PT
12 REVIEW-MULTICASE in PT
13 LETTER in PT
14 COMMENT in PT
15 EDITORIAL in PT
16 HISTORICAL-ARTICLE in PT
17 #11 or #12 or #13 or #14 or #15 or #16
18 #10 not #17
19 ((systematic* or quantitativ* or methodologic*) near (review* or overview*)) in TI,AB
20 (meta anal* or metaanal*) in TI,AB
21 (integrativ* research review* or research integration) in TI,AB
22 (quantitativ* synthes*) in TI,AB
23 (pooling* or (pooled analys*) or (mantel* haenszel*)) in TI,AB
24 (peto* or der simonian* or dersimonian* or fixed effect* or random effect*) in TI,AB
25 #19 or #20 or #21 or #22 or #23 or #24
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Search terms
26 #18 or #25
27 (TG=ANIMAL) not ((TG=HUMAN) and (TG=ANIMAL))
28 #26 not #27
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Table 02. Original data for all outcomes
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
Aggel-Leijssen
2001
Weight change
(kg) at 12
weeks (mean
+/- SD): diet
= -14.8 +/-
5.3 kg, diet
+ exercise =
-15.2 + / - 6.3
kg
Aggel-Leijssen
2001b
Weight change
(kg) at 12
weeks (mean
+/- SD):
exercise = 86.5
+/- 10.2 kg
(pre) to 87.1
+/- 10.1 kg
(post), control
= 94.7 + / -
14.0 kg (pre)
to 94.5 +/-
14.5 kg (post)
Change in
BMI at 12
weeks (mean
+/- SD):
exercise = 32.1
+/- 2.9 (pre) to
32.4 +/- 3.0
(post), control
= 33.3 + / - 3.8
(pre) to 33.1
+/- 3.9 (post)
Change in
% body fat
at 12 weeks
(mean +/- SD):
exercise = 42.6
+/- 3.1 (pre) to
42.8 +/- 2.4
(post), control
= 44.4 + / - 3.0
(pre) to 44.9
+/- 3.2 (post)
Change in
WHR at 12
weeks (mean
+/- SD):
exercise = 0.89
+/- 0.04 (pre)
to 0.89 +/-
0.05 (post),
control = 0.90
+ / - 0.03 (pre)
to 0.88 +/-
0.03 (post)
Change in
VO2 max
(ml/min) at
12 weeks
(mean +/-
SD): exercise =
2126 +/- 168
(pre) to 2188
+/- 291 (post),
control = 1913
+ / -460 (pre)
to 1966 +/-
359 (post)
Aggel-Leijssen
2002
Weight
change (kg)
at 12 weeks
(mean +/-
SE): vigorous
exercise =
105.5 +/- 6.6
kg (pre) to
105.1 +/- 6.2
kg (post),
moderate
exercise =
102.7 + / -
Change in
BMI at 12
weeks (mean
+/- SE):
vigorous
exercise =
32.2 +/- 1.6
(pre) to 32.1
+/- 1.3 (post),
moderate
exercise = 31.6
+ / - 3.1 (pre)
to 31.7 +/- 3.1
Change in
% body fat
at 12 weeks
(mean +/-
SE): vigorous
exercise =
31.3 +/- 4.3
(pre) to 31.8
+/- 4.4 (post),
moderate
exercise = 31.9
+ / - 2.4 (pre)
to 31.5 +/- 2.2
Change in
VO2 max
(ml/min) at
12 weeks
(mean +/-
SE): vigorous
exercise =
3312 +/- 448
(pre) to 3820
+/- 453 (post),
moderate
exercise =
3191 + / - 532
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
10.8 kg (pre)
to 103.1 +/-
11.4 kg (post),
control = 96.5
+/- 10.3 kg
(pre) to 95.9
+/- 9.6 kg
(post)
(post), control
= 31.5 +/- 2.4
(pre) to 31.4
+/- 2.5 (post)
(post), control
= 31.6 +/- 5.1
(pre) to 31.7
+/- 5.0 (post)
(pre) to 3556
+/- 542 (post),
control = 2944
+/- 443 (pre)
to 3019 +/-
557 (post)
Anderson
1999
Weight change
(kg) at 16
weeks (mean
+/- SD): diet +
exercise = -8.3
+/- 3.8 kg, diet
= -7.9 +/- 4.2
kg
Triglyceride
change (%)
at 16 weeks
(mean +/- SD):
diet + exercise
= -17.9 +/-
18.2 %, diet =
-14.6 +/- 32.4
%
Cholesterol
change (%)
at 16 weeks
(mean +/- SD):
diet + exercise
= -10.9 +/- 8.0
%, diet = -9.3
+/- 12.4 %
Systolic blood
pressure
change (%)
at 16 weeks
(mean +/- SD):
diet + exercise
= -7.0 +/- 7.1
%, diet = -7.9
+/- 11.6 %
Anderssen
1996
BMI change at
12 months:
exercise =
-0.65 (SE=
1.5), diet =
-1.6 (SE=1.8),
diet + exercise
= - 2.2 (SE=
1.8), control =
0.4 (SE=0.8)
Fasting serum
glucose change
at 12 months:
exercise =
-0.09 (SE=
0.4), diet =
-0.2 (SE=0.5),
diet + exercise
= - 0.3 (SE=
0.6), control =
0.07 (SE=0.5)
VO2 max
change at
12 months:
exercise = 4.0
(SE=0.1), diet
= 1.7 (SE=
0.1), diet +
exercise = 6.7
(SE=0.1)
Change in
total energy
intake at
12 months:
exercise = 92
(SE=602),
diet = -1679
(SE=450), diet
+ exercise =
-1414 (SE=
574)
Balkestein
1999
Weight change
(kg) at 12
weeks: diet +
exercise = 102
+/- 3 (SEM)
(pre) to 87
Change in
BMI at 12
weeks: diet +
exercise = 33
+/- 1 (SEM)
(pre) to 28
Change in
systolic blood
pressure
(mmHg) at 12
weeks: diet +
exercise = 130
Change in
diastolic
blood pressure
(mmHg) at 12
weeks: diet +
exercise = 82
4
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
+/- 2 (SEM)
(post), diet
= 103 +/- 3
(SEM) (pre)
to 88 +/- 2
(SEM) (post)
+/- 1 (SEM)
(post), diet
= 32 +/- 1
(SEM) (pre)
to 27 +/- 1
(SEM) (post)
+/- 2 (SEM)
(pre) to 122
+/- 2 (SEM)
(post), diet
= 127+/- 3
(SEM) (pre)
to 117 +/- 2
(SEM) (post)
+/- 2 (SEM)
(pre) to 77
+/- 2 (SEM)
(post), diet
= 80 +/- 2
(SEM) (pre)
to 72 +/- 2
(SEM) (post)
Cox 1996 Weight
change (kg)
at 16 weeks:
Vigorous
exercise =
-1.43 kg
(SEM=0.3),
light exercise
= -0.35 kg
(SEM=0.3)
Systolic blood
pressure
change
(mmHg) at
16 weeks:
vigorous
exercise =
-3.2 mmHg
(95%CI, -5.6
to -0.7), light
exercise =
-3.6 mmHg
(95%CI, -5.6
to -1.6)
Diastolic
blood pressure
change
(mmHg) at
16 weeks:
vigorous
exercise =
-2.9 mmHg
(95%CI, -4.2
to -1.6), light
exercise =
-3.1 mmHg
(95%CI, -4.9
to -1.3)
Cox 2004 Weight change
(kg) at 16
weeks: exercise
= -1.55 kg
(95%CI, -0.25
to -2.84), diet
= -10.88 kg
(95%CI, -8.53
to -13.23),
diet + exercise
= - 11.66 kg
(95%CI, -8.32
to -15.01),
Waist-to-hip
ratio change
at 16 weeks:
exercise = 0.00
(95%CI, -0.02
to 0.02), diet
= -0.02 (95%
CI, -0.01 to
-0.03), diet
+ exercise =
- 0.03 (95%
CI, -0.01 to
-0.05), control
BMI change
at 16 weeks:
exercise = -0.1
(95% CI, -0.6
to 0.3), diet =
-3.1 (95% CI,
-4.0 to -2.3),
diet + exercise
= - 2.9 (95%
CI, -4.0 to
-1.7), control =
0.1 (95% CI,
-0.2 to 0.4)
Fasting serum
glucose change
(mmol/L) at
16 weeks:
exercise =
-0.01 (95%
CI, -0.3 to
0.26), diet =
0.03 (95% CI,
-0.19 to 0.26),
diet + exercise
= - 0.09 (95%
CI, -0.37 to
Glycated
haemoglobin
change (%)
at 16 weeks:
exercise = 0.13
(95% CI,
-0.08 to 0.36),
diet = 0.14
(95% CI, 0.01
to 0.26), diet
+ exercise = -
0.03 (95% CI,
-0.26 to 0.20),
VO2 max
change
(L/min) at 16
weeks: exercise
= 0.59 (95%
CI, 0.67 to
0.51), diet =
0.01 (95% CI,
0.08 to 0.12),
diet + exercise
= 0.65 (95%
CI, 0.49 to
0.79), control
Change in
energy intake
(kj/d) at 16
weeks: exercise
= 787 (95%
CI, -755 to
2330), diet =
-4023 (95%
CI, -5015 to
-3032), diet
+ exercise = -
4804 (95%
CI, -6402
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
control = -0.44
kg (95%CI,
0.4 to -1.3)
= 0.01 (95%
CI, 0.01 to
-0.01)
0.19), control
= 0.51 (95%
CI, 0.04 to
0.98)
control = 0.21
(95% CI, -0.1
to 0.53)
= 0.09 (95%
CI, -0.01 to
0.20)
to -3205),
control = -802
(95% CI,
-3383 to 1780)
Gillett 1987 Weight
change (lb)
at 16 weeks
(mean +/-
SD): exercise
= 165.3 +/-
16.9 lb (pre)
to 159.8 +/-
15.9 lb (post),
control =
166.3 + / -
17.7 lb (pre) to
160.4 +/- 17.7
lb (post)
Change in
% body fat
at 16 weeks
(mean +/- SD):
exercise = 42.3
+/- 6.7 (pre) to
40.6 +/- 4.9
(post), control
= 42.8 + / - 6.0
(pre) to 38.8
+/- 6.6 (post)
Change in
total serum
cholesterol
(mg%) at
16 weeks
(mean +/-
SD): exercise
= 204.9 +/-
45.6 (pre) to
209.7 +/- 45.4
(post), control
= 195.1 + / -
36.0 (pre) to
185.4 +/- 56.4
(post)
Change in
total serum
triglycerides
(mg%) at
16 weeks
(mean +/-
SD): exercise
= 116.3 +/-
64.2 (pre) to
149.1 +/- 85.8
(post), control
= 109.3 + / -
53.3 (pre) to
122.0 +/- 74.5
(post)
Change in
total serum
glucose (mg%)
at 16 weeks
(mean +/- SD):
exercise = 94.3
+/- 10.0 (pre)
to 91.3 +/- 7.6
(post), control
= 88.5 + / - 6.2
(pre) to 86.2
+/- 5.7 (post)
Change in
systolic blood
pressure
(mmHg) at
16 weeks
(mean +/-
SD): exercise
= 115.0 +/-
13.3 (pre) to
110.8 +/- 11.2
(post), control
= 109.8 + / -
8.1 (pre) to
103.5 +/- 5.9
(post)
Change in
diastolic
blood pressure
(mmHg) at
16 weeks
(mean +/- SD):
exercise = 79.2
+/- 12.2 (pre)
to 72.1 +/- 8.7
(post), control
= 70.6 + / - 8.3
(pre) to 66.5
+/- 6.2 (post)
Gordon 1997 Weight change
(kg) at 12
weeks (mean
+/- SD):
exercise = -1.0
+/- 1.8 kg, diet
= - 5.8 +/-
3.9 kg, diet +
exercise = - 7.1
+/- 2.9 kg
Body fat (%)
change at 12
weeks (mean
+/- SD):
exercise = -0.5
+/- 1.0 %, diet
= - 1.6 +/-
1.3 %, diet +
exercise = - 2.4
+/- 1.7 %
Maximal
oxygen
uptake change
(ml/min) at
12 weeks
(mean +/-
SD): exercise =
-1.0 +/- 1.8 kg,
diet = - 5.8 +/-
3.9 kg, diet +
exercise = - 7.1
+/- 2.9 kg
Systolic blood
pressure
change
(mmHg) at
12 weeks
(mean +/-
SD): exercise
= -9.9 +/- 6.4
mmHg , diet =
- 11.3 +/- 12.1
mmHg, diet
+ exercise = -
12.5 +/- 6.3
mmHg
Diastolic
blood pressure
change
(mmHg) at
12 weeks
(mean +/-
SD): exercise
= -5.9 +/- 4.6
mmHg , diet
= - 7.5 +/- 4.3
mmHg, diet +
exercise = - 7.9
+/- 4.3 mmHg
Hays 2004 Weight change % body fat Physical Maximal Resting energy
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
(kg) at 14
weeks (mean
+/- SD): diet =
-3.2 +/- 1.2 kg,
diet + exercise
= -4.8 + / - 0.9
kg, control =
-0.1 +/- 0.6 kg
change at 14
weeks (mean
+/- SD): diet =
-2.2 +/- 1.2 %,
diet + exercise
= -3.5 + / - 0.7
%, control =
0.2 +/- 0.6 %
activity
(kcal/wk) from
baseline to
week 14 (mean
and SEM):
diet - pre =
3034 (SEM=
411) and post
= 3495 (SEM=
954) kcal/wk;
diet + exercise
- pre = 4549
(SEM=808)
and post =
4988 (SEM=
477) kcal/wk,
control - pre =
4730 (SEM=
679) and post
= 5157 (SEM=
820) kcal/wk
aerobic
capacity
(mL/kg/
minute
peak oxygen
consumption)
from baseline
to week 14
(mean and
SEM): diet
- pre = 17.8
(SEM=0.9)
and post =
17.8 (SEM=
1.0); diet +
exercise - pre =
18.5 (SEM=
1.3) and post =
23.1 (SEM=
1.3), control
- pre = 17.0
(SEM=1.0)
and post =
17.0 (SEM=
1.0)
expenditure
(kcal/d) from
baseline to
week 14 (mean
and SEM):
diet - pre =
1356 (SEM=
69) and post =
1343 (SEM=
68) kcal/d; diet
+ exercise - pre
= 1286 (SEM=
53) and post =
1224 (SEM=
52) kcal/d,
control - pre =
1357 (SEM=
92) and post =
1318 (SEM=
81) kcal/d
Hellenius
1993
BMI at 6
months:
exercise = -0.3
(95% CI, -0.5
to -0.01), diet
= -0.3 (95%
CI, -0.6 to
0.03), diet +
exercise = -
0.6 (95% CI,
Waist
circumference
(cm) at 6
months:
exercise = -2.2
(95% CI, -3.2
to -1.3), diet =
-1.3 (95% CI,
-2.5 to -0.1),
diet + exercise
WHR at
6 months:
exercise =
-0.06 (95%
CI, -0.08 to
-0.05), diet =
-0.05 (95%
CI, -0.07 to
-0.02), diet
+ exercise =
Systolic blood
pressure
(mmHg) at
6 months:
exercise = -5
(95% CI, -9 to
-0.3), diet = -7
(95% CI, -10
to -3), diet +
exercise = - 4
Diastolic
blood pressure
(mmHg) at
6 months:
exercise = -4
(95% CI, -7 to
-2), diet = -6
(95% CI, -8
to -4), diet +
exercise = - 2
Total serum
cholesterol
(mmol/L) at
6 months:
exercise =
-0.12 (95%
CI, -0.35 to
0.11), diet =
-0.19 (95%
CI, -0.49 to
Total serum
triglycerides
(mmol/L) at
6 months:
exercise =
-0.10 (95%CI,
-0.34 to 0.13),
diet = 0.03
(95%CI, -0.09
to 0.15), diet
Change in
energy intake
(kj/d) at
6 months:
exercise = 8928
(SD=1522) pre
to 8564 (SD=
1494) post,
diet = 8160
(SD=1751) pre
Change in
number
of exercise
sessions per
month at
6 months:
exercise = 5.1
(SD=7.3) pre
to 11.7 (SD=
6.7) post, diet
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
-0.9 to -0.3),
control = 0.3
(95% CI, 0.1
to 0.5)
= - 3.0 (95%
CI, -3.9 to
-2.0), control =
0.3 (95% CI,
-0.5 to 1.1)
- 0.05 (95%
CI, -0.06 to
-0.03), control
= -0.05 (95%
CI, -0.07 to
-0.04)
(95% CI, -7 to
-1), control =
-1 (95% CI, -3
to 4)
(95% CI, -4 to
1), control =
-1 (95% CI, -3
to 1)
0.11), diet +
exercise = -
0.45 (95%
CI, -0.77 to
-0.13), control
= -0.13 (95%
CI, -0.33 to
0.07)
+ exercise = -
0.12 (95%CI,
-0.31 to 0.08),
control = 0.06
(95%CI, -0.08
to 0.20)
to 7795 (SD=
1506) post,
diet + exercise
= 8635 (SD=
2055) pre to
7705 (SD=
1674) post,
control = 9391
(SD=2723) pre
to 8753 (SD=
2387) post
= 5.6 (SD=
7.0) pre to 6.1
(SD=7.0) post,
diet + exercise
= 5.1 (SD=
7.3) pre to 9.9
(SD=6.8) post,
control = 5.3
(SD=7.1) pre
to 5.4 (SD=
7.4) post
Irwin 2003 Weight change
(kg) at 3
months:
Intervention
= -0.5 kg
(95%CI,
-1 to 0.1),
control = 0 kg
(95%CI, -0.6
to 0.5); Weight
change (kg) at
12 months:
Intervention
= -1.3 kg
(95%CI, -2 to
-0.5), control
= 0.1 kg
(95%CI, -0.6
to 0.8)
BMI change
at 3 months:
Intervention =
-0.2 (95%CI,
-0.4 to 0),
control = 0
(95%CI, -0.2
to 0.2); BMI
change at
12 months:
Intervention =
-0.3 (95%CI,
-0.6 to -0.1),
control = 0.3
(95%CI, 0 to
0.6)
Waist
circumference
(cm) change
at 3 months:
Intervention
= -0.5 cm
(95%CI, -1.2
to 0.2), control
= -0.1 cm
(95%CI, -0.8
to 0.6); Waist
circumference
change at
12 months:
Intervention
= -1.0 cm
(95%CI,
-1.8 to -0.1),
control = 0.1
cm (95%CI,
-0.8 to 0.9)
Hip
circumference
(cm) change
at 3 months:
Intervention
= -0.1 cm
(95%CI, -0.6
to 0.6), control
= 0.2 cm
(95%CI, -0.4
to 0.9); Hip
circumference
change at
12 months:
Intervention
= -1.5 cm
(95%CI,
-2.3 to -0.7),
control = 0.1
cm (95%CI,
-0.6 to 0.9)
DXA total
body fat
change (kg) at
12 months:
Intervention
= -1.4 kg
(95%CI, -2 to
-0.8), control
= -0.1 kg
(95%CI, -0.6
to 0.6)
DXA % fat
change at
12 months:
Intervention
= -1.2 %
(95%CI,
-1.6 to -0.8),
control = -0.2
% (-0.6 to 0.2)
Intra-
abdominal fat
change (CT
- g / cm2) at
12 months:
Intervention =
-8.5 (95%CI,
-15.1 to -2.0),
control = 0.1
(95%CI, -6.7
to 6.6)
Subcutaneous
fat change (CT
- g / cm2) at
12 months:
Intervention =
-21.2 (95%CI,
-34.4 to -7.9),
control = 7.6
(95%CI, -5.8
to 20.9)
Maximal
oxygen
consumption,
% change at
12 months:
Intervention
= 11.7 %
(95%CI,
8.8 to 14.6),
control = 0.7
% (95%CI,
-2.2 to 3.6)
Jakicic 1995 Weight change
(kg) at 20
weeks (mean
VO2 max
change by
20 weeks
BMI change
by 20 weeks
(mean +/-
Systolic blood
pressure
change by
Diastolic
blood pressure
change by
4
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
+/- SD):
Vigorous
exercise = -6.4
+/- 4.5 kg,
light exercise =
-8.9 +/- 5.3 kg
(mean +/-
SD): Vigorous
exercise =
1842.2 +/-
412.5 ml/min
pre to 1944.9
+/- 337.3
ml/min post,
light exercise
= 2030.9 +/-
466.4 ml/min
pre to 2132.2
+/- 401.9
ml/min post
SD): Vigorous
exercise = 33.7
+/- 4.8 pre
to 31.3 +/-
5.0 post, light
exercise = 34.2
+/- 3.7 pre to
30.9 +/- 3.8
post
20 weeks
(mean +/-
SD): Vigorous
exercise =
117.9 +/- 14.9
mmHg pre to
114.0 +/- 16.0
mmHg post,
light exercise =
117.0 +/- 10.5
mmHg pre to
114.3 +/- 10.8
mmHg post
20 weeks
(mean +/-
SD): Vigorous
exercise =
80.0 +/- 10.1
mmHg pre to
75.9 +/- 9.3
mmHg post,
light exercise
= 80.6 +/- 7.0
mmHg pre to
75.4 +/- 8.4
mmHg post
Jakicic 2003 Weight change
(kg) at 12
months (mean
+/- SD):
Vigorous
intensity,
high duration
exercise =
-8.9 +/- 7.3
kg, Moderate
intensity,
high duration
exercise =
-8.2 +/- 7.6
kg, Moderate
intensity,
moderate
duration
exercise =
-6.3 +/- 5.6
kg, Vigorous
BMI change
from baseline
to 12 months
(mean +/-
SD): Vigorous
intensity,
high duration
exercise =
32.9 +/- 3.9
(pre) to 29.5
+/- 4.8 (post),
Moderate
intensity,
high duration
exercise =
32.3 +/- 3.9
(pre) to 29.2
+/- 4.8 (post),
Moderate
intensity,
moderate
Change in
leisure-time
physical
activity
(min/week)
from baseline
to 12 months
(mean +/-
SD): Vigorous
intensity,
high duration
exercise =
134.3 +/-
288.8 (pre)
to 175.7 +/-
170.3 (post),
Moderate
intensity,
high duration
exercise =
160.6 +/-
Change in
energy intake
(kcal/day)
from baseline
to 12 months
(mean +/-
SD): Vigorous
intensity,
high duration
exercise =
2099 +/- 796
(pre) to 1471
+/- 532 (post),
Moderate
intensity,
high duration
exercise =
2116 +/- 981
(pre) to 1557
+/- 531 (post),
Moderate
Change in car-
diorespiratory
fitness (mL/kg)
from baseline
to 12 months
(mean +/-
SD): Vigorous
intensity,
high duration
exercise =
20.2 +/- 2.9
(pre) to 24.5
+/- 4.8 (post),
Moderate
intensity,
high duration
exercise =
19.4 +/- 3.2
(pre) to 22.1
+/- 4.0 (post),
Moderate
Change in
cardiorespi-
ratory fitness
at 12 months
(mean +/-
SD): Vigorous
intensity,
high duration
exercise = 22
+/- 19.9%,
Moderate
intensity,
high duration
exercise =
14.9 +/- 18.6
%, Moderate
intensity,
moderate
duration
exercise =
13.5 +/- 16.9
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
intensity,
moderate
duration
exercise = -7
+/- 6.4 kg
duration
exercise =
32.7 +/- 4.3
(pre) to 30.3
+/- 4.5 (post),
Vigorous
intensity,
moderate
duration
exercise = 32.7
+/- 4.6 (pre) to
30.2 +/- 4.6
(post)
248.8 (pre)
to 189.9 +/-
119.0 (post),
Moderate
intensity,
moderate
duration
exercise =
108.3 +/-
221.7 (pre)
to 206.6 +/-
242.0 (post),
Vigorous
intensity,
moderate
duration
exercise =
115.2 +/-
245.3 (pre)
to 140.1 +/-
115.4 (post)
intensity,
moderate
duration
exercise =
2027 +/- 743
(pre) to 1350
+/- 422 (post),
Vigorous
intensity,
moderate
duration
exercise = 2200
+/- 875 (pre)
to 1449 +/-
502 (post)
intensity,
moderate
duration
exercise =
19.7 +/- 3.7
(pre) to 22.2
+/- 4.6 (post),
Vigorous
intensity,
moderate
duration
exercise = 19.7
+/- 3.1 (pre) to
23.3 +/- 4.5
(post)
%, Vigorous
intensity,
moderate
duration
exercise = 18.9
+/- 16.9 %
Janssen 2002 Weight change
(kg) at 16
weeks (mean
+/- SD): diet =
-10 +/- 3.9 kg,
diet + aerobic
exercise =
-11.1 + / -
4.4 kg, diet
+ resistance
exercise = -10
+/- 3 kg
BMI change
at 16 weeks
(mean +/-
SD): diet =
-4 +/-1.4,
diet + aerobic
exercise = -4.2
+ / - 1.2, diet
+ resistance
exercise = 3.9
+/- 1
Fasting serum
glucose change
(mmol/L)
at 16 weeks
(mean +/-
SD): diet =
-0.1 +/-0.4,
diet + aerobic
exercise = -0.1
+ / - 0.5, diet
+ resistance
exercise = -0.1
+/- 0.4
Serum
triglyceride
change
(mmol/L)
at 16 weeks
(mean +/-
SD): diet =
-0.3 +/-1.6,
diet + aerobic
exercise = -0.3
+ / - 0.5, diet
+ resistance
exercise = -0.4
+/- 0.8
Fasting serum
cholesterol
change
(mmol/L)
at 16 weeks
(mean +/-
SD): diet =
-0.8 +/-0.4,
diet + aerobic
exercise = -0.4
+ / - 0.6, diet
+ resistance
exercise = -0.6
+/- 0.45
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
Jeffery 1998 Weight change
(kg) at 12
months:
exercise = -6.5
+/- 6.5 kg,
control = -8.3
+ / - 4.3 kg
Jeffery 2003 Weight change
(kg) at 6
months (mean
+/- SD): Diet =
-8.1 +/- 7.4 kg,
diet + exercise
= -9 +/- 7.1 kg;
Weight change
(kg) at 12
months: Diet =
-6.1 +/- 8.8 kg,
Diet + exercise
= -8.5 +/- 7.9
kg; Weight
change (kg) at
18 months:
Diet = -4.1 +/-
7.3 kg, Diet +
exercise = -6.7
+/- 8.1 kg
Energy
expenditure
(kcal/wk) from
baseline to 18
months (mean
and SD): diet
- pre = 1286
(SD=1258)
and post =
1629 (SD=
1483) kcal/wk;
diet + exercise
- pre = 1278
(SD=1369)
and post =
2317 (SD=
1854) kcal/wk
Energy intake
(kcal/d) from
baseline to 18
months (mean
and SD): diet
- pre = 2071
(SD=1058)
and post =
1641 (SD=
742) kcal/d;
diet + exercise
- pre = 2189
(SD=1066)
and post =
1631 (SD=
670) kcal/d
Kiernan 2001 Weight change
(kg) at 12
months (mean
+/- SD): diet +
exercise = -6.9
+/- 5.5 kg, diet
= - 4.5 +/- 5.7
kg
BMI change
at 12 months
(mean +/- SD):
diet + exercise
= -2.3 +/- 1.8,
diet = - 1.6 +/-
1.8
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Leutholtz
1995
Weight change
(kg) at 12
weeks (mean
+/- SD):
vigorous
exercise =
-15.7 +/-
5.3 kg, light
exercise = -
15.0 +/- 8.4 kg
Body fat
(%) change
at 12 weeks
(mean +/-
SD): vigorous
exercise = -9.6
+/- 3.2 %,
light exercise =
- 8.3 +/- 2.9 %
Manning 1991 Weight change
(kg) at 12
weeks (mean
+/- SEM):
exercise = 84.1
+/- 3.5 kg (pre)
to 85.5 +/-
3.6 kg (post),
control = 87.0
+/- 4.2 kg (pre)
to 87.3 +/- 4.3
kg (post)
Change in
BMI at 12
weeks (mean
+/- SEM):
exercise = 31.4
+/- 1.3 (pre) to
32.0 +/- 1.4
(post), control
= 32.8 +/- 1.4
(pre) to 33.0
+/- 1.4 (post)
Change in
energy intake
(kcal/day)
at 12 weeks
(mean +/-
SEM): exercise
= 1618 +/- 135
kcal/day (pre)
to 1675 +/-
96 kcal/day
(post), control
= 1658 +/- 144
kcal/day (pre)
to 1728 +/-
102 kcal/day
(post)
Change in
total serum
cholesterol
(mg/dl) at 12
weeks (mean
+/- SEM):
exercise = 200
+/- 10 (pre)
to 198 +/- 11
(post), control
= 197 +/- 15
(pre) to 205
+/- 15 (post)
Change in
total serum
triglycerides
(mg/dl) at 12
weeks (mean
+/- SEM):
exercise = 111
+/- 10 (pre)
to 126 +/- 12
(post), control
= 106 +/- 20
(pre) to 114
+/- 30 (post)
Neumark
1995
Weight change
(kg) at 3
months (mean
+/- SD):
exercise = -3.6
+/- 2.6 kg,
control = -3.8
+/- 2.0 kg
Change
in waist
circumference
(cm) at 3
months (mean
+/- SD):
exercise = -7.4
+/- 7.0 cm,
control = -8.5
+/- 8.9 cm
Nieman 1998 Weight change
(kg) at 3
Change in
BMI at 3
Change in %
body fat at 3
Change in
VO2 max
Change
in serum
Change
in serum
Change in
serum glucose
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
months (mean
+/- SEM):
exercise = 88.4
+/- 2.9 (pre) to
87.4 +/- 2.8
(post), diet =
90.6 +/- 3.8
(pre) to 82.8
+/- 3.7 (post),
diet+ exercise
= 89.9 +/- 2.5
(pre) to 81.8
+/- 2.3 (post),
control = 90.5
+/- 2.4 (pre) to
89.7 +/- 2.5
(post)
months (mean
+/- SEM):
exercise = 32.3
+/- 1.1 (pre) to
32.0 +/- 1.1
(post), diet =
34.2 +/- 1.6
(pre) to 31.3
+/- 1.5 (post),
diet+ exercise
= 32.6 +/- 1.0
(pre) to 29.7
+/- 0.9 (post),
control = 32.8
+/- 1.0 (pre) to
32.5 +/- 1.0
(post)
months (mean
+/- SEM):
exercise = 43.1
+/- 1.3 (pre) to
42.1 +/- 1.5
(post), diet =
44.3 +/- 1.1
(pre) to 40.1
+/- 1.4 (post),
diet+ exercise
= 43.3 +/- 1.1
(pre) to 39.6
+/- 0.9 (post),
control = 43.4
+/- 1.0 (pre) to
42.3 +/- 1.1
(post)
(ml/min) at 3
months (mean
+/- SEM):
exercise = 2018
+/- 61 (pre) to
2303 +/- 73
(post), diet =
1993 +/- 45
(pre) to 2018
+/- 59 (post),
diet+ exercise
= 1995 +/- 73
(pre) to 2157
+/- 72 (post),
control = 1986
+/- 77 (pre) to
2057 +/- 69
(post)
cholesterol
(mmol/L) at 3
months (mean
+/- SEM):
exercise = 5.6
+/- 0.2 (pre)
to 5.7 +/- 0.2
(post), diet =
5.4 +/- 0.2
(pre) to 4.8
+/- 0.2 (post),
diet+ exercise
= 5.3 +/- 0.2
(pre) to 4.7
+/- 0.2 (post),
control = 5.1
+/- 0.2 (pre)
to 5.1 +/- 0.2
(post)
triglycerides
(mmol/L) at 3
months (mean
+/- SEM):
exercise = 1.6
+/- 0.2 (pre)
to 1.8 +/- 0.2
(post), diet =
1.6 +/- 0.2
(pre) to 1.4
+/- 0.1 (post),
diet+ exercise
= 1.5 +/- 0.1
(pre) to 1.3
+/- 0.1 (post),
control = 1.5
+/- 0.1 (pre)
to 1.8 +/- 0.2
(post)
(mmol/L) at 3
months (mean
+/- SEM):
exercise = 5.1
+/- 0.2 (pre)
to 4.9 +/- 0.1
(post), diet =
5.2 +/- 0.2
(pre) to 4.8
+/- 0.1 (post),
diet+ exercise
= 5.3 +/- 0.2
(pre) to 4.9
+/- 0.1 (post),
control = 5.1
+/- 0.2 (pre)
to 5.4 +/- 0.2
(post)
Pritchard 1997 Weight change
(%) at 12
months (mean
+/- SD):
exercise =
-3 +/- 0.5%,
diet = -7.2 +/-
0.9%, control
= 1.0 +/- 0.5%
BMI change
(%) at 12
months (mean
+/- SD):
exercise = -4.4
+/- 0.7%, diet
= -8.2 +/-
0.9%, control
= 1.0 +/- 0.7%
Change in
energy intake
(%) at 12
months (mean
+/- SD):
exercise = 3.1
+/- 2.7%, diet
= -30.4 +/-
3.8%, control
= 5.5 +/- 4.7%
Change in
physical
activity (%)
at 12 months
(mean +/-
SD): exercise =
15.6 +/- 0.1%,
diet = 3.4 +/-
1.2%, control
= 6.4 +/- 1.7%
Raz 1994 Change in
BMI at 12
weeks (mean
+/- SD):
exercise = 31.8
+/- 4.6 (pre) to
Change in
serum glucose
(mmol/l) at
12 weeks
(mean +/- SD):
exercise = 11.4
Change
in serum
cholesterol
(mmol/l) at
12 weeks
(mean +/- SD):
Change
in serum
triglycerides
at 12 weeks
(mean +/- SD):
exercise = 2.0
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
31.5 +/- 4.3
(post), control
= 30.2 + / - 4.7
(pre) to 30.6
+/- 4.2 (post)
+/- 2.3 (pre) to
10.2 +/- 3.3
(post), control
= 11.8 + / - 4.6
(pre) to 12.3
+/- 4.4 (post)
exercise = 5.7
+/- 1.0 (pre)
to 5.6 +/- 1.0
(post), control
= 6.0 + / - 1.1
(pre) to 6.0 +/-
1.0 (post)
+/- 0.7 (pre)
to 1.9 +/- 0.7
(post), control
= 2.1 + / - 0.6
(pre) to 2.2 +/-
0.1 (post)
Ross 1996 Weight change
(kg) at 16
weeks (mean
+/- SD): diet
= -11.4 +/-
3.5 kg, diet
+ aerobic
exercise =
-11.6 + / -
3.7 kg, diet
+ resistance
exercise =
-13.2 +/- 4.1
kg
Waist
circumference
change (cm)
at 16 weeks
(mean +/- SD):
diet = -8.5
+/- 4.0 cm,
diet + aerobic
exercise =
-12.9 + / -
4.0 cm, diet
+ resistance
exercise =
-11.9 +/- 4.0
cm
WHR change
at 16 weeks
(mean +/-
SD): diet =
-0.03 +/- 0.03,
diet + aerobic
exercise =
-0.05 + / -
0.05, diet
+ resistance
exercise =
-0.05 +/- 0.02
Schwartz 1987 Weight change
(kg) at 3
months (mean
+/- SD):
exercise = -2.8
+/- 3.6 kg, diet
= - 13.1 +/-
6.1 kg
Change in
calorie intake
(kcal/day) at
3 months
(mean +/- SD):
exercise = 174
+/- 187, diet =
- 199 +/- 256
Change in
triglycerides
(mg/dL) at
3 months
(mean +/- SD):
exercise = -2
+/- 35, diet = -
54 +/- 67
Change in
cholesterol
(mg/dL) at
3 months
(mean +/- SD):
exercise = 7 +/-
17, diet = - 29
+/- 27
Schwartz 1990 Weight change
(kg) at 3
months (mean
+/- SD):
Change in
% body fat
at 3 months
(mean +/- SD):
Change in
calorie intake
(kcal/day) at
3 months
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
exercise = -2.3
+/- 3.4 kg, diet
= - 13.6 +/-
6.7 kg
exercise = -2.3
+/- 2.3 %, diet
= - 5.9 +/- 3.5
%
(mean +/- SD):
exercise = 202
+/- 176 kcal/d,
diet = - 247 +/-
275 kcal/d
Stefanick 1998 Weight change
(kg) at 12
months (mean
+/- SD):
exercise = -0.5
+/- 2.8 kg, diet
= - 2.8 +/-
3.5 kg, diet
+ exercise = -
3.7 +/- 4.0 kg,
control = 0.7
+/- 3.5 kg
Change
in serum
cholesterol
(mmol/L) at
12 months
(mean +/- SD):
exercise = -5.4
+/- 4.7, diet =
- 10.6 +/- 4.5,
diet + exercise
= - 19.1 +/-
4.5, control =
-2.5 +/- 4.5
Change
in serum
triglycerides
(mmol/L) at
12 months
(mean +/-
SD): exercise =
-12.9 +/- 6.9,
diet = - 5.3
+/- 7.9, diet +
exercise = - 8.6
+/- 7.2, control
= -5.4 +/- 7.9
Change in
serum glucose
(mmol/L) at
12 months
(mean +/- SD):
exercise = -6.7
+/- 3.0, diet =
- 7.7 +/- 2.8,
diet + exercise
= - 7.8 +/- 3.1,
control = -3.2
+/- 3.6
Change in
systolic blood
pressure
(mmHg) at
12 months
(mean +/- SD):
exercise = -0.8
+/- 2.8, diet =
- 2.6 +/- 2.8,
diet + exercise
= - 3.1 +/- 2.7,
control = - 1.0
+/- 2.8
Change in
diastolic
blood pressure
(mmHg) at
12 months
(mean +/- SD):
exercise = -1.2
+/- 2.6, diet =
- 1.1 +/- 2.3,
diet + exercise
= - 2.9 +/- 2.4,
control = 0.6
+/- 2.4
Stensel 1994 Weight change
(kg) at 12
months:
exercise = 79.3
+/- 1.5 (SEM)
(pre) to 79.1
+/- 1.5 (SEM)
(post), control
= 77.6 + / - 2.5
(SEM) (pre) to
78.3 +/- 2.7
(SEM) (post)
BMI change at
12 months:
exercise = 25.4
+/- 0.4 (SEM)
(pre) to 25.4
+/- 0.4 (SEM)
(post), control
= 24.8 + / - 0.7
(SEM) (pre) to
25.0 +/- 0.7
(SEM) (post)
Change in %
body fat at
12 months:
exercise = 28.7
+/- 0.8 (SEM)
(pre) to 27.6
+/- 0.7 (SEM)
(post), control
= 29.5 + / - 1.5
(SEM) (pre) to
29.3 +/- 1.5
(SEM) (post)
Change in
WHR at
12 months:
exercise =
0.95 +/- 0.01
(SEM) (pre) to
0.94 +/- 0.01
(SEM) (post),
control = 0.95
+ / - 0.01
(SEM) (pre) to
0.94 +/- 0.01
(SEM) (post)
Svendsen 1993 Weight change
(kg) at 12
weeks (mean
WHR change
at 12 weeks
(mean +/- SD):
VO2 max
change at 12
weeks (mean
Change
in serum
cholesterol
Change
in serum
triglycerides
Change in
energy intake
(kj/d) at 12
Change in
systolic blood
pressure
Change in
diastolic
blood pressure
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
+/- SD): diet
= - 9.5 +/-
2.8 kg, diet
+ exercise = -
10.3 +/- 3.0 kg
diet = - 0.3
+/- 0.3, diet +
exercise = - 0.3
+/- 0.4
+/- SD): diet
= 2.3 +/- 2.2
ml/kg/min,
diet + exercise
= 6.9 +/- 9.6
ml/kg/min
(mmol/L)
at 12 weeks
(mean +/- SD):
diet = - 1.36
+/- 0.84, diet
+ exercise = -
1.23 +/- 0.67
(mmol/L)
at 12 weeks
(mean +/- SD):
diet = - 0.5 +/-
0.69, diet +
exercise = - 0.3
+/- 0.46
weeks (mean
+/- SD): diet
= - 3287 +/-
2076, diet +
exercise = -
3526 +/- 2378
(mmHg) at 12
weeks (mean
+/- SD): diet
= - 13 +/- 12,
diet + exercise
= - 11 +/- 11
(mmHg) at 12
weeks (mean
+/- SD): diet =
- 7 +/- 8, diet +
exercise = - 9
+/- 8
Thong 2000 Weight change
(kg) at 3
months:
exercise = -7.6
kg +/- 0.1
(SE), diet = -
7.4 kg +/- 0.2
(SE), control =
0.1 kg +/- 0.3
(SE)
BMI change
at 3 months:
exercise = -2.4
+/- 0.1 (SE),
diet = - 2.4
+/- 0.1 (SE),
control = -0.3
+/- 0.1 (SE)
WHR change
at 3 months:
exercise =
-0.03 +/- 0.01
(SE), diet = -
0.04 +/- 0.01
(SE), control
= -0.001 +/-
0.01 (SE)
VO2 max
change at
3 months:
exercise = 8.8
+/- 0.9 (SE),
diet = 0.8
+/- 0.9 (SE),
control = 0.07
+/- 1.3 (SE)
Utter 2000 Weight change
(kg) at 3
months (mean
+/- SE):
exercise = 80.5
+/- 2.0 (pre) to
80.7 +/- 2.1
(post), control
= 91.8 +/- 6.5
(pre) to 93.3
+/- 6.3 (post)
Change in
% body fat
at 3 months
(mean +/- SE):
exercise = 40.7
+/- 1.1 (pre) to
39.6 +/- 1.2
(post), control
= 41.9 +/- 1.3
(pre) to 42.3
+/- 1.3 (post)
Wadden 1997 Weight change
(kg) at 24
weeks (mean
+/- SD): diet
+ exercise = -
16.4 +/- 7.3
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
kg, diet = -
16.7 +/- 5.5 kg
Wallace 1997 Weight change
(kg) at 14
weeks (mean
+/- SD):
vigorous
exercise =
-4.2 +/- 4.1
kg, moderate
exercise = - 1.9
+/- 5.1 kg
Change in
% body fat
at 14 weeks
(mean +/-
SD): vigorous
exercise =
-6.9 +/- 1.3
%, moderate
exercise = - 1.4
+/- 1.4 %
WHR change
at 14 weeks
(mean +/-
SD): vigorous
exercise =
-0.06 +/- 0.01,
moderate
exercise = -
0.04 +/- 0.01
Change
in serum
triglycerides
(mg/dL) at
14 weeks
(mean +/-
SD): vigorous
exercise =
-43.8 +/- 13.6,
moderate
exercise = -
31.9 +/- 12.2
Change in
blood pressure
(mmHg) at
14 weeks
(mean +/-
SD): vigorous
exercise =
-14.6 +/- 5.5,
moderate
exercise = - 8.3
+/- 6.8
Change in
serum glucose
(mg/dL) at
14 weeks
(mean +/-
SD): vigorous
exercise =
-11.1 +/- 2.9,
moderate
exercise = - 5.9
+/- 2.6
Whatley 1994 Weight
change (kg)
at 3 months
(mean +/-
SD): vigorous
exercise =
-19.6 +/- 4.2
kg, moderate
exercise = -
15.8 +/- 4.2 kg
Change in
WHR at
3 months
(mean +/-
SD): vigorous
exercise =
-0.02 +/- 0.03,
moderate
exercise = -
0.04 +/- 0.06
Change in
VO2 max
(L/min) at
3 months
(mean +/-
SD): vigorous
exercise = -
0.05 +/- 0.02,
moderate
exercise = -
0.08 +/- 0.18
Wing 1988 Weight change
(kg) at 12
months (mean
+/- SD): diet
+ exercise =
104.1 +/- 6.0
kg (pre) to
96.2 +/- 6.5
kg (post), diet
BMI change
at 12 months
(mean +/- SD):
diet + exercise
= 37.5 +/- 1.9
(pre) to 34.6
+/- 2.1 (post),
diet = 37.9 +/-
1.7 (pre) to
Change in
HbA1c at 12
months (mean
+/- SD): diet +
exercise = 10.6
+/- 0.5 (pre)
to 9.2 +/- 0.5
(post), diet =
10.9 +/- 0.5
Change
in serum
cholesterol
(mmol/l) at 12
months (mean
+/- SD): diet +
exercise = 4.9
+/- 0.3 (pre)
to 5.2 +/- 0.3
Change
in serum
triglycerides
(mmol/l) at 12
months (mean
+/- SD): diet +
exercise = 2.5
+/- 0.6 (pre)
to 1.9 +/- 0.3
Change in
serum glucose
(mmol/l) at 12
months (mean
+/- SD): diet +
exercise = 11.6
+/- 0.6 (pre)
to 9.9 +/- 0.8
(post), diet =
5
7
E
x
e
rc
ise
fo
r
o
v
e
rw
e
ig
h
t
o
r
o
b
e
sity
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
0
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
= 102.0 +/-
5.0 kg (pre) to
98.2 +/- 4.9 kg
(post)
36.6 +/- 1.8
(post)
(pre) to 10.1
+/- 0.4 (post)
(post), diet =
4.8 +/- 0.2
(pre) to 5.2 +/-
0.2 (post)
(post), diet =
1.8 +/- 0.3
(pre) to 1.9 +/-
0.2 (post)
12.6 +/- 0.7
(pre) to 11.8
+/- 1.0 (post)
Wing 1998 Weight change
(kg) at 6
months:
exercise = -2.1
+/- 4.2 kg, diet
= - 9.1 +/-
6.4 kg, diet
+ exercise = -
10.3 +/- 7.7
kg, control =
-1.5 +/- 2.7 kg
Change in
BMI at 6
months:
exercise = -0.8
+/- 1.5, diet =
- 3.3 +/- 2.2,
diet + exercise
= - 3.7 +/- 2.6,
control = -0.6
+/- 1.0
Change
in fasting
plasma glucose
(mmol/l) at
6 months:
exercise = 0.0
+/- 0.7, diet =
- 0.2 +/- 0.4,
diet + exercise
= - 0.2 +/- 0.4,
control = 0.1
+/- 0.5
Change in
fasting plasma
cholesterol
(mmol/l) at
6 months:
exercise = 0.12
+/- 0.72, diet =
- 0.49 +/- 0.71,
diet + exercise
= - 0.33 +/-
0.61, control =
0.12 +/- 0.5
Change in
fasting plasma
triglycerides
(mmol/l) at
6 months:
exercise = 0.1
+/- 1.6, diet =
- 0.3 +/- 1.5,
diet + exercise
= - 0.7 +/- 1.5,
control = -0.3
+/- 1.3
Change in
systolic blood
pressure
(mmHg) at
6 months:
exercise = -2.4
+/- 18.9, diet =
- 10.2 +/- 9.2,
diet + exercise
= - 12.3 +/-
9.5, control =
-2.0 +/- 10.5
Change in
diastolic
blood pressure
(mmHg) at
6 months:
exercise = -1.7
+/- 12.2, diet =
- 6.2 +/- 6.9,
diet + exercise
= - 6.9 +/-
10.4, control =
-2.2 +/- 8.0
Wirth 1985 Weight change
(kg) at 4
months (mean
+/- SD):
exercise = 81.9
+/- 10.6 kg
(pre) to 81.6
+/- 10.7 kg
(post), control
= 86.6 +/- 12.9
kg (pre) to
88.2 +/- 14.5
kg (post)
Change in
% body fat
at 4 months
(mean +/- SD):
exercise = 24.0
+/- 4.6 (pre) to
22.1 +/- 3.1
(post), control
= 24.7 +/- 3.1
(pre) to 25.6
+/- 2.5 (post)
Change in
resting systolic
blood pressure
(mmHg) at
4 months
(mean +/- SD):
exercise = 137
+/- 5.1 (pre) to
123 +/- 5.1
(post), control
= 132 +/- 5.6
(pre) to 132
+/- 4.9 (post)
Change in
total serum
cholesterol
(mg/dL) at
4 months
(mean +/- SD):
exercise = 273
+/- 57 (pre)
to 260 +/- 52
(post), control
= 299 +/- 61
(pre) to 294
+/- 58 (post)
Wood 1988 Weight change
(kg) at 12
months (mean
+/- SD):
exercise = -4.0
Change in
energy intake
(kj/day) at
12 months
(mean +/-
Change in
VO2 max
(ml/kg/min)
at 12 months
(mean +/- SD):
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Table 02. Original data for all outcomes (Continued )
Study ID Outcome 1 Outcome 2 Outcome 3 Outcome 4 Outcome 5 Outcome 6 Outcome 7 Outcome 8 Outcome 9
+/- 3.9 kg, diet
= - 7.2 +/- 3.7
kg, control =
0.6 +/- 3.7 kg
SD): exercise =
-873 +/- 2558
kj/day, diet
= -1429 +/-
1887 kj/day,
control =
-433 +/- 2071
kj/day
exercise = 4.1
+/- 5.9, diet =
0.0 +/- 3.2,
control = -2.4
+/- 3.2
Wood 1991 Weight change
(kg) at 12
months (mean
+/- SD): diet +
exercise = -3.4
+/- 4.9 kg, diet
= - 2.3 +/- 6.0
kg
Change
in serum
triglycerides
(mmol/L) at
12 months
(mean +/- SD):
diet + exercise
= -0.2 +/- 0.6,
diet = - 0.03
+/- 0.5
Change
in serum
cholesterol
(mmol/L) at
12 months
(mean +/- SD):
diet + exercise
= -0.32 +/-
0.70, diet = -
0.4 +/- 0.6
Change in
systolic blood
pressure
(mmHg) at 12
months (mean
+/- SD): diet +
exercise = -4.5
+/- 8, diet = -
4.1 +/- 7.3
Change in
diastolic
blood pressure
(mmHg) at 12
months (mean
+/- SD): diet +
exercise = -3.5
+/- 4.9, diet =
- 2.3 +/- 5.9
SD=standard deviation; SE=standard error; SEM=standard error of the mean; CI=confidence interval; kg=kilograms; lb=pounds; BMI=
body mass index; WHR=waist-hip ratio; DXA=dual-energy x-ray absorptiometry; mmHg=millimetres of mercury; kcal=kilocalories;
VO2max=maximal oxygen uptake; HDL=high-density lipoprotein; LDL=low-density lipoprotein; mmol/L=millimoles per litre
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Table 03. Summary of Main Findings from Comparisons for Each Outcome
Intervention Body Weight BMI Systolic BP Diastolic BP Cholesterol Triglycerides HDL Glucose
Exercise versus
No Treatment
Exercise
increased
weight loss
compared with
no treatment.
Exercisers lost
0.5 to 7.6 kg.
No treatment
changed weight
from 0.1 kg loss
to 0.7 kg gain.
Exercise reduced
BMI more than
no treatment.
Exercisers lost
between 0.3 and
2.4 kg/m2.
No treatment
changed BMI
from 0.03 loss to
0.4 kg/m2 gain.
Exercise did
not reduce SBP
significantly
more than no
treatment.
Exercisers
reduced SBP
by 0.8 to 5.0
mmHg.
No treatment
reduced SBP by
1.0 mmHg.
Exercise reduced
DBP 2.1 mmHg
more than no
treatment.
Exercisers
reduced DBP
0.8 to 5.0
mmHg.
No treatment
changed DBP
from 1.0 loss to
0.6 mmHg gain.
Exercise did
not reduce
cholesterol
significantly
more than no
treatment.
Exercisers
reduced
cholesterol 0.1
to 0.3 mmol/L.
No treatment
reduced
cholesterol 0.1
to 0.2 mmol/L.
Exercise reduced
TG 0.2 mmol/L
more than no
treatment.
Exercisers
reduced TG 0.1
to 0.2 mmol/L.
No treatment
changed TG
from no change
to 0.1 mmol/L
gain.
Exercise
increased HDL
more than no
treatment.
Exercisers
increased HDL
0.01 to 0.1
mmol/L.
No treatment
changed HDL
from 0.02 loss to
0.01 mmol/L
gain.
Exercise reduced
glucose 0.2
mmol/L
more than no
treatment.
Exercisers
reduced glucose
0.1 to 0.4
mmol/L.
No treatment
changed glucose
from 0.2 loss
to 0.1 mmol/L
gain.
High versus
Low Intensity
Exercise
Increasing
the intensity
increased the
weight loss if
participants were
not on a diet.
High intensity
exercisers lost
1.5 kg more than
low intensity
exercisers.
Range of weight
change for
high intensity
exercisers was
from 1.3 kg to
8.9 kg loss.
Range for
low intensity
exercisers was
from 6.3 kg loss
to 0.1 kg gain.
Insufficient data
for analysis.
SBP was reduced
with both high
and low intensity
exercise.
Increased
exercise intensity
did not reduce
SBP significantly
more than low
intensity.
No consistent
effect of exercise
on DBP was
seen.
Increased
exercise
intensity did
not reduce DBP
significantly
more than low
intensity.
Insufficient data
for analysis.
TG was reduced
by both high and
low intensity
exercise.
Increased
exercise intensity
did not reduce
TG significantly
more than low
intensity.
HDL was
increased by
both high and
low intensity
exercise.
Increased
exercise intensity
increased HDL
0.1 mmol/L
more than low
intensity.
Glucose was
reduced with
both high and
low intensity
exercise.
High intensity
reduced glucose
0.3 mmol/L
more than low
intensity.
Range was 0.01
to 0.6 reduction
with high
intensity and 0.3
reduction to 0.5
gain with low
intensity.
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Table 03. Summary of Main Findings from Comparisons for Each Outcome (Continued )
Intervention Body Weight BMI Systolic BP Diastolic BP Cholesterol Triglycerides HDL Glucose
High versus
Low Intensity
Exercise with
Dietary Change
Increasing the
intensity did
not increase the
weight loss if
they were on a
diet.
Range of weight
change was 6.4
kg to 19.6 kg loss
across groups.
Insufficient data
for analysis.
SBP was reduced
with both high
and low intensity
exercise.
Increased
exercise intensity
did not reduce
SBP significantly
more than low
intensity.
No consistent
effect of exercise
on DBP was
seen.
Increased
exercise
intensity did
not reduce DBP
significantly
more than low
intensity.
No consistent
effect of exercise
on cholesterol
was seen.
Increased
exercise intensity
did not reduce
cholesterol
significantly
more than low
intensity.
TG was reduced
by both high and
low intensity
exercise.
Increased
exercise intensity
did not reduce
TG significantly
more than low
intensity.
HDL was
reduced by
both high and
low intensity
exercise.
Increased
exercise intensity
did not reduce
TG significantly
more than low
intensity.
Glucose was
reduced by
both high and
low intensity
exercise.
Increased
exercise
intensity did not
reduce glucose
significantly
more than low
intensity.
Exercise versus
Diet
Diet resulted in
greater weight
losses compared
with exercise.
Dieters lost 2.8
kg to 13.6 kg of
weight.
Exercisers lost
0.5 kg to 7.6 kg
of weight.
Diet resulted
in greater BMI
reductions than
exercise.
Both lost 0.3 to
2.4 kg/m2.
Diet resulted
in greater SBP
reductions than
exercise.
Diet reduced
SBP by 2.2
mmHg more
than exercise.
Range of SBP
change with
diet was 2.6 to
11.3 mmHg
reduction.
Range with
exercise was 0.8
to 9.9 mmHg
reduction.
There was
no significant
difference
between diet and
exercise for DBP
reduction.
Dieters reduced
DBP from 1.1 to
7.5 mmHg.
Exercisers
reduced DBP
from 1.2 to 5.9
mmHg.
Diet resulted
in greater
cholesterol
reductions than
exercise.
Range of
cholesterol
change with
diet was 0.2 to
0.7 mmol/L
reduction.
Range with
exercise was 0.2
to 0.3 mmol/L
reduction.
There was
no significant
difference
between diet and
exercise on TG.
Range of TG
change with diet
was 0.6 loss to
0.03 mmol/L
gain.
Range with
exercise was 0.2
loss to 0.1 gain.
There was
no significant
difference
between diet
and exercise on
HDL.
Range of HDL
change with diet
was 0.01 loss
to 0.1 mmol/L
gain.
Range with
exercise was 0.01
to 0.1 mmol/L
gain.
Diet resulted in
greater glucose
reductions than
exercise.
Diet reduced
glucose by 0.1
mmol/L more
than exercise.
Range of glucose
reduction with
diet was 0.2 to
0.4 mmol/L.
Range with
exercise was 0.0
to 0.4 mmol/L
reduction.
Exercise and
Diet versus Diet
Alone
Diet + exercise
resulted in
greater weight
loss than diet
alone.
Dieters +
Diet + exercise
resulted
in greater
reductions in
BMI than diet
alone.
Adding exercise
to diet did not
improve SBP
reduction.
Range of SBP
change was 2.6
Adding exercise
to diet did not
improve DBP
reduction.
Range of DBP
change was 1.1
Adding exercise
to diet did
not improve
cholesterol
reduction.
Range of
Adding exercise
to diet did not
improve TG
reduction.
Range of TG
change was 0.69
Adding exercise
to diet did not
improve HDL
levels.
Range of HDL
change was 0.1
Adding exercise
to diet did not
improve glucose
levels.
Range of glucose
change was 0.1
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Table 03. Summary of Main Findings from Comparisons for Each Outcome (Continued )
Intervention Body Weight BMI Systolic BP Diastolic BP Cholesterol Triglycerides HDL Glucose
exercisers lost
1.1 kg more than
dieters.
Range of
weight change
for dieters +
exercisers was
from 3.4 kg to
17.7 kg loss.
Range for dieters
was 2.3 kg to
16.7 kg loss.
Dieters +
exercisers lost
0.4 kg/m2 more
than dieters.
Range of
BMI change
for dieters +
exercisers was
from 0.6 to 4.0
kg/m2 loss.
Range for dieters
was 0.3 to 4.0
kg/m2 loss.
to 13 mmHg
drop across
groups.
to 9.0 mmHg
drop across
groups.
cholesterol
change was 0.15
to 1.4 mmol/L
drop across
groups.
drop to 0.03
mmol/L gain
across groups.
drop to 0.1
mmol/L gain
across groups.
to 0.4 mmol/L
loss across
groups.
kg=kilograms; BMI=body mass index; HDL=high-density lipoprotein; LDL=low-density lipoprotein; BP=blood pressure; HbA1c=
glycosylated haemoglobin; WHR=waist--hip ratio
kg=kilograms; m=metres; BMI=body mass index; BP=blood pressure; HDL=high-density lipoprotein; LDL=low-density lipoprotein;
TG=triglycerides; HbA1c=glycosylated haemoglobin; mmHg=millimetres of mercury; mmol/L=millimoles per litre
n=number of subjects; N=mean;kg=kilograms;BMI=body mass index;HDL=high-density lipoprotein;LDL=low-density lipopro-
tein;BP=blood pressure;HbA1c=glycosylated haemoglobin;WHR=waist--hip ratio
n=number of subjects; N=mean;kg=kilograms;BMI=body mass index;HDL=high-density lipoprotein;LDL=low-density lipopro-
tein;BP=blood pressure;HbA1c=glycosylated haemoglobin;WHR=waist--hip ratio
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A N A L Y S E S
Comparison 01. Exercise versus no treatment control
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight change in kilograms Weighted Mean Difference (Fixed) 95% CI Totals not selected
02 Change in body mass index
(BMI)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
03 Change in systolic blood
pressure (mmHg)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
04 Change in diastolic blood
pressure (mmHg)
2 259 Weighted Mean Difference (Fixed) 95% CI -2.09 [-3.68, -0.51]
05 Change in total serum
cholesterol (mmol/l)
3 348 Weighted Mean Difference (Fixed) 95% CI 0.03 [-0.09, 0.15]
06 Change in serum triglycerides
(mmol/l)
3 348 Weighted Mean Difference (Fixed) 95% CI -0.18 [-0.31, -0.05]
07 Change in serum HDL
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
08 Change in fasting serum
glucose (mmol/l)
2 273 Weighted Mean Difference (Fixed) 95% CI -0.17 [-0.30, -0.05]
Comparison 02. Exercise versus diet
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight change in kilograms Weighted Mean Difference (Fixed) 95% CI Totals not selected
02 Change in body mass index
(BMI)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
03 Change in systolic blood
pressure (mmHg)
4 361 Weighted Mean Difference (Fixed) 95% CI 2.24 [0.29, 4.20]
04 Change in diastolic blood
pressure (mmHg)
4 361 Weighted Mean Difference (Fixed) 95% CI 0.87 [-0.44, 2.18]
05 Change in total serum
cholesterol (mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
06 Change in serum triglycerides
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
07 Change in serum HDL
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
08 Change in fasting serum
glucose (mmol/l)
3 354 Weighted Mean Difference (Fixed) 95% CI 0.10 [-0.00, 0.20]
Comparison 03. Exercise + diet versus diet alone
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight change in kilograms 33 2157 Weighted Mean Difference (Fixed) 95% CI -1.02 [-1.32, -0.72]
02 Change in body mass index
(BMI)
5 452 Weighted Mean Difference (Fixed) 95% CI -0.43 [-0.71, -0.14]
03 Change in systolic blood
pressure (mmHg)
6 615 Weighted Mean Difference (Fixed) 95% CI -0.11 [-1.48, 1.25]
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04 Change in diastolic blood
pressure (mmHg)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
05 Change in total serum
cholesterol (mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
06 Change in serum triglycerides
(mmol/l)
6 619 Weighted Mean Difference (Fixed) 95% CI -0.08 [-0.18, 0.02]
07 Change in serum HDL
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
08 Change in fasting serum
glucose (mmol/l)
4 407 Weighted Mean Difference (Fixed) 95% CI -0.01 [-0.10, 0.08]
Comparison 04. High versus low intensity exercise with dietary change
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight change in kilograms 7 224 Weighted Mean Difference (Fixed) 95% CI -0.08 [-1.20, 1.04]
02 Change in body mass index
(BMI)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
03 Change in systolic blood
pressure (mmHg)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
04 Change in diastolic blood
pressure (mmHg)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
05 Change in serum cholesterol
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
06 Change in serum triglycerides
(mmol/l)
2 65 Weighted Mean Difference (Fixed) 95% CI 0.00 [-0.18, 0.19]
07 Change in serum HDL
(mmol/l)
2 65 Weighted Mean Difference (Fixed) 95% CI 0.03 [-0.05, 0.11]
08 Change in serum glucose
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
Comparison 05. High versus low intensity exercise without dietary change
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Weight change in kilograms 4 317 Weighted Mean Difference (Fixed) 95% CI -1.47 [-2.28, -0.66]
02 Change in systolic blood
pressure (mmHg)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
03 Change in diastolic blood
pressure
Weighted Mean Difference (Fixed) 95% CI Totals not selected
04 Change in serum triglycerides
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
05 Change in serum HDL
(mmol/l)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
06 Change in serum glucose
(mmol/l)
2 46 Weighted Mean Difference (Fixed) 95% CI -0.31 [-0.45, -0.16]
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Analysis 01.01. Comparison 01 Exercise versus no treatment control, Outcome 01 Weight change in
kilograms
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 01 Weight change in kilograms
Study Exercise No treatment Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Stefanick 1998 90 -0.50 (2.80) 91 0.65 (3.50) -1.15 [ -2.07, -0.23 ]
Thong 2000 16 -7.60 (0.40) 8 -0.10 (0.80) -7.50 [ -8.09, -6.91 ]
Wood 1988 47 -4.00 (3.90) 42 0.60 (3.70) -4.60 [ -6.18, -3.02 ]
-10.0 -5.0 0 5.0 10.0
Favours exercise Favours no treatment
Analysis 01.02. Comparison 01 Exercise versus no treatment control, Outcome 02 Change in body mass
index (BMI)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 02 Change in body mass index (BMI)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Anderssen 1996 49 -0.65 (1.50) 43 0.36 (0.80) -1.01 [ -1.49, -0.53 ]
Hellenius 1993 39 -0.30 (0.80) 39 0.30 (0.64) -0.60 [ -0.92, -0.28 ]
Thong 2000 16 -2.40 (0.40) 8 -0.03 (0.30) -2.37 [ -2.66, -2.08 ]
-10.0 -5.0 0 5.0 10.0
Favours exercise Favours no treatment
Analysis 01.03. Comparison 01 Exercise versus no treatment control, Outcome 03 Change in systolic blood
pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 03 Change in systolic blood pressure (mmHg)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 -5.00 (13.90) 39 -1.00 (6.40) -4.00 [ -8.80, 0.80 ]
Stefanick 1998 90 -0.80 (8.10) 91 -1.00 (7.70) 0.20 [ -2.10, 2.50 ]
-10.0 -5.0 0 5.0 10.0
Favours exercise Favours no treatment
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Analysis 01.04. Comparison 01 Exercise versus no treatment control, Outcome 04 Change in diastolic blood
pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 04 Change in diastolic blood pressure (mmHg)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 39 -4.00 (8.00) 39 -1.00 (6.40) 24.3 -3.00 [ -6.22, 0.22 ]
Stefanick 1998 90 -1.20 (6.50) 91 0.60 (6.00) 75.7 -1.80 [ -3.62, 0.02 ]
Total (95% CI) 129 130 100.0 -2.09 [ -3.68, -0.51 ]
Test for heterogeneity chi-square=0.40 df=1 p=0.52 I² =0.0%
Test for overall effect z=2.59 p=0.01
-10.0 -5.0 0 5.0 10.0
Favours exercise Favours no treatment
Analysis 01.05. Comparison 01 Exercise versus no treatment control, Outcome 05 Change in total serum
cholesterol (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 05 Change in total serum cholesterol (mmol/l)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 39 -0.12 (0.73) 39 -0.13 (0.64) 16.4 0.01 [ -0.29, 0.31 ]
Stefanick 1998 90 -0.14 (0.56) 91 -0.19 (0.51) 62.5 0.05 [ -0.11, 0.21 ]
Wood 1988 47 -0.25 (0.64) 42 -0.23 (0.65) 21.1 -0.02 [ -0.29, 0.25 ]
Total (95% CI) 176 172 100.0 0.03 [ -0.09, 0.15 ]
Test for heterogeneity chi-square=0.21 df=2 p=0.90 I² =0.0%
Test for overall effect z=0.46 p=0.6
-1.0 -0.5 0 0.5 1.0
Favours exercise Favours no treatment
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Analysis 01.06. Comparison 01 Exercise versus no treatment control, Outcome 06 Change in serum
triglycerides (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 06 Change in serum triglycerides (mmol/l)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 39 -0.10 (0.75) 39 0.06 (0.45) 21.3 -0.16 [ -0.43, 0.11 ]
Stefanick 1998 90 -0.14 (0.54) 91 0.06 (0.70) 48.5 -0.20 [ -0.38, -0.02 ]
Wood 1988 47 -0.16 (0.50) 42 0.00 (0.60) 30.1 -0.16 [ -0.39, 0.07 ]
Total (95% CI) 176 172 100.0 -0.18 [ -0.31, -0.05 ]
Test for heterogeneity chi-square=0.10 df=2 p=0.95 I² =0.0%
Test for overall effect z=2.77 p=0.006
-1.0 -0.5 0 0.5 1.0
Favours exercise Favours no treatment
Analysis 01.07. Comparison 01 Exercise versus no treatment control, Outcome 07 Change in serum HDL
(mmol/l)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 07 Change in serum HDL (mmol/l)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 0.01 (0.18) 39 -0.02 (0.21) 0.03 [ -0.06, 0.12 ]
Stefanick 1998 90 0.04 (0.14) 91 0.01 (0.13) 0.03 [ -0.01, 0.07 ]
Wood 1988 47 0.11 (0.15) 42 -0.02 (0.11) 0.13 [ 0.08, 0.18 ]
-1.0 -0.5 0 0.5 1.0
Favours no treatment Favours exercise
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Analysis 01.08. Comparison 01 Exercise versus no treatment control, Outcome 08 Change in fasting serum
glucose (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 01 Exercise versus no treatment control
Outcome: 08 Change in fasting serum glucose (mmol/l)
Study Exercise No treatment Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderssen 1996 49 -0.09 (0.40) 43 0.07 (0.45) 51.2 -0.16 [ -0.34, 0.02 ]
Stefanick 1998 90 -0.37 (0.49) 91 -0.18 (0.72) 48.8 -0.19 [ -0.37, -0.01 ]
Total (95% CI) 139 134 100.0 -0.17 [ -0.30, -0.05 ]
Test for heterogeneity chi-square=0.06 df=1 p=0.81 I² =0.0%
Test for overall effect z=2.73 p=0.006
-4.0 -2.0 0 2.0 4.0
Favours exercise Favours no treatment
Analysis 02.01. Comparison 02 Exercise versus diet, Outcome 01 Weight change in kilograms
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 01 Weight change in kilograms
Study Exercise Diet Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Gordon 1997 14 -1.00 (1.80) 15 -5.80 (3.90) 4.80 [ 2.61, 6.99 ]
Pritchard 1997 21 -2.60 (3.00) 18 -6.40 (3.30) 3.80 [ 1.81, 5.79 ]
Schwartz 1987 14 -2.80 (3.60) 12 -13.10 (6.10) 10.30 [ 6.37, 14.23 ]
Schwartz 1990 18 -2.30 (3.40) 13 -13.60 (6.70) 11.30 [ 7.33, 15.27 ]
Stefanick 1998 90 -0.50 (2.80) 95 -2.80 (3.50) 2.30 [ 1.39, 3.21 ]
Thong 2000 16 -7.60 (0.40) 14 -7.40 (0.80) -0.20 [ -0.66, 0.26 ]
Wing 1998 33 -2.10 (4.20) 35 -9.10 (6.40) 7.00 [ 4.44, 9.56 ]
Wood 1988 47 -4.00 (3.90) 42 -7.20 (3.70) 3.20 [ 1.62, 4.78 ]
-10.0 -5.0 0 5.0 10.0
Favours exercise Favours diet
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Analysis 02.02. Comparison 02 Exercise versus diet, Outcome 02 Change in body mass index (BMI)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 02 Change in body mass index (BMI)
Study Exercise Diet Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Anderssen 1996 49 -0.65 (1.50) 52 -1.60 (1.80) 0.95 [ 0.31, 1.59 ]
Hellenius 1993 39 -0.30 (0.80) 40 -0.30 (1.02) 0.00 [ -0.40, 0.40 ]
Thong 2000 16 -2.40 (0.40) 14 -2.40 (0.80) 0.00 [ -0.46, 0.46 ]
Wing 1988 33 -0.80 (1.50) 35 -3.30 (2.20) 2.50 [ 1.61, 3.39 ]
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Analysis 02.03. Comparison 02 Exercise versus diet, Outcome 03 Change in systolic blood pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 03 Change in systolic blood pressure (mmHg)
Study Exercise Diet Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Gordon 1997 14 -9.90 (6.40) 15 -11.30 (12.10) 7.8 1.40 [ -5.58, 8.38 ]
Hellenius 1993 39 -5.00 (13.90) 40 -7.00 (11.30) 12.2 2.00 [ -3.59, 7.59 ]
Stefanick 1998 90 -0.80 (8.10) 95 -2.60 (7.80) 72.5 1.80 [ -0.49, 4.09 ]
Wing 1998 33 -2.40 (18.90) 35 -10.20 (9.20) 7.5 7.80 [ 0.67, 14.93 ]
Total (95% CI) 176 185 100.0 2.24 [ 0.29, 4.20 ]
Test for heterogeneity chi-square=2.54 df=3 p=0.47 I² =0.0%
Test for overall effect z=2.25 p=0.02
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Analysis 02.04. Comparison 02 Exercise versus diet, Outcome 04 Change in diastolic blood pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 04 Change in diastolic blood pressure (mmHg)
Study Exercise Diet Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Gordon 1997 14 -5.90 (4.60) 15 -7.50 (4.30) 16.2 1.60 [ -1.65, 4.85 ]
Hellenius 1993 39 -4.00 (8.00) 40 -6.00 (6.50) 16.5 2.00 [ -1.22, 5.22 ]
Stefanick 1998 90 -1.20 (6.50) 95 -1.10 (5.10) 59.8 -0.10 [ -1.79, 1.59 ]
Wing 1998 33 -1.70 (12.20) 35 -6.20 (6.90) 7.6 4.50 [ -0.25, 9.25 ]
Total (95% CI) 176 185 100.0 0.87 [ -0.44, 2.18 ]
Test for heterogeneity chi-square=4.18 df=3 p=0.24 I² =28.2%
Test for overall effect z=1.30 p=0.2
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Analysis 02.05. Comparison 02 Exercise versus diet, Outcome 05 Change in total serum cholesterol (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 05 Change in total serum cholesterol (mmol/l)
Study Exercise Diet Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 -0.12 (0.73) 40 -0.19 (0.97) 0.07 [ -0.31, 0.45 ]
Schwartz 1987 14 0.18 (0.44) 12 -0.74 (0.70) 0.92 [ 0.46, 1.38 ]
Stefanick 1998 90 -0.14 (0.56) 95 -0.27 (0.50) 0.13 [ -0.02, 0.28 ]
Wing 1998 33 0.12 (0.72) 35 -0.49 (0.70) 0.61 [ 0.27, 0.95 ]
Wood 1988 47 -0.25 (0.60) 42 -0.36 (0.56) 0.11 [ -0.13, 0.35 ]
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Analysis 02.06. Comparison 02 Exercise versus diet, Outcome 06 Change in serum triglycerides (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 06 Change in serum triglycerides (mmol/l)
Study Exercise Diet Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 -0.10 (0.75) 40 0.03 (0.39) -0.13 [ -0.39, 0.13 ]
Schwartz 1987 14 -0.02 (0.40) 12 -0.60 (0.75) 0.58 [ 0.11, 1.05 ]
Stefanick 1998 90 -0.14 (0.54) 95 -0.06 (0.70) -0.08 [ -0.26, 0.10 ]
Wing 1998 33 0.12 (1.64) 35 -0.30 (1.50) 0.42 [ -0.33, 1.17 ]
Wood 1988 47 -0.16 (0.50) 42 -0.27 (0.72) 0.11 [ -0.15, 0.37 ]
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Analysis 02.07. Comparison 02 Exercise versus diet, Outcome 07 Change in serum HDL (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 07 Change in serum HDL (mmol/l)
Study Exercise Diet Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 0.01 (0.18) 40 0.01 (0.19) 0.00 [ -0.08, 0.08 ]
Schwartz 1987 14 0.08 (0.08) 12 0.10 (0.23) -0.02 [ -0.16, 0.12 ]
Stefanick 1998 90 0.04 (0.14) 95 -0.01 (0.13) 0.05 [ 0.01, 0.09 ]
Wing 1998 33 0.02 (0.16) 35 0.10 (0.20) -0.08 [ -0.17, 0.01 ]
Wood 1988 47 0.11 (0.15) 42 0.12 (0.16) -0.01 [ -0.07, 0.05 ]
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Analysis 02.08. Comparison 02 Exercise versus diet, Outcome 08 Change in fasting serum glucose (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 02 Exercise versus diet
Outcome: 08 Change in fasting serum glucose (mmol/l)
Study Exercise Diet Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderssen 1996 49 -0.09 (0.40) 52 -0.21 (0.50) 31.6 0.12 [ -0.06, 0.30 ]
Stefanick 1998 90 -0.37 (0.49) 95 -0.43 (0.43) 55.3 0.06 [ -0.07, 0.19 ]
Wing 1998 33 0.00 (0.70) 35 -0.20 (0.40) 13.1 0.20 [ -0.07, 0.47 ]
Total (95% CI) 172 182 100.0 0.10 [ 0.00, 0.20 ]
Test for heterogeneity chi-square=0.91 df=2 p=0.63 I² =0.0%
Test for overall effect z=1.93 p=0.05
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Analysis 03.01. Comparison 03 Exercise + diet versus diet alone, Outcome 01 Weight change in kilograms
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 01 Weight change in kilograms
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Weight change - all studies
Aggel-Leijssen 2001 20 -15.20 (6.30) 17 -14.80 (5.30) 0.6 -0.40 [ -4.14, 3.34 ]
Gordon 1997 19 -7.10 (2.90) 15 -5.80 (3.90) 1.6 -1.30 [ -3.67, 1.07 ]
Hays 2004 11 -4.80 (0.90) 11 -3.20 (1.20) 11.5 -1.60 [ -2.49, -0.71 ]
Janssen 2002 25 -10.50 (3.60) 13 -10.00 (3.90) 1.4 -0.50 [ -3.05, 2.05 ]
Kiernan 2001 81 -6.90 (5.50) 71 -4.50 (5.70) 2.8 -2.40 [ -4.19, -0.61 ]
Neumark 1995 21 -3.60 (2.60) 19 -3.80 (2.00) 4.4 0.20 [ -1.23, 1.63 ]
Nieman 1998 22 -7.80 (3.30) 26 -8.00 (3.10) 2.7 0.20 [ -1.62, 2.02 ]
Ross 1996 22 -12.40 (3.90) 11 -11.40 (3.50) 1.3 -1.00 [ -3.63, 1.63 ]
Stefanick 1998 91 -3.70 (4.00) 95 -2.80 (3.50) 7.8 -0.90 [ -1.98, 0.18 ]
Svendsen 1993 48 -10.30 (3.00) 50 -9.50 (2.80) 6.9 -0.80 [ -1.95, 0.35 ]
Wadden 1997 91 -16.40 (7.30) 29 -16.70 (5.50) 1.5 0.30 [ -2.20, 2.80 ]
Whatley 1994 16 -17.70 (4.20) 7 -13.10 (2.40) 1.2 -4.60 [ -7.32, -1.88 ]
Wing 1998 31 -10.30 (7.70) 35 -9.10 (6.40) 0.8 -1.20 [ -4.64, 2.24 ]
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(. . . Continued)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Wood 1991 81 -3.40 (4.90) 71 -2.30 (6.00) 2.9 -1.10 [ -2.86, 0.66 ]
Subtotal (95% CI) 579 470 47.5 -1.05 [ -1.49, -0.62 ]
Test for heterogeneity chi-square=16.68 df=13 p=0.21 I² =22.1%
Test for overall effect z=4.73 p<0.00001
02 Weight change - males
Aggel-Leijssen 2001 20 -15.20 (6.30) 17 -14.80 (5.30) 0.6 -0.40 [ -4.14, 3.34 ]
Ross 1996 22 -12.40 (3.90) 11 -11.40 (3.50) 1.3 -1.00 [ -3.63, 1.63 ]
Subtotal (95% CI) 42 28 2.0 -0.80 [ -2.95, 1.35 ]
Test for heterogeneity chi-square=0.07 df=1 p=0.80 I² =0.0%
Test for overall effect z=0.73 p=0.5
03 Weight change - females
Janssen 2002 25 -10.50 (3.60) 13 -10.00 (3.90) 1.4 -0.50 [ -3.05, 2.05 ]
Neumark 1995 21 -3.60 (2.60) 19 -3.80 (2.00) 4.4 0.20 [ -1.23, 1.63 ]
Nieman 1998 22 -7.80 (3.30) 26 -8.00 (3.10) 2.7 0.20 [ -1.62, 2.02 ]
Svendsen 1993 48 -10.30 (3.00) 50 -9.50 (2.80) 6.9 -0.80 [ -1.95, 0.35 ]
Wadden 1997 91 -16.40 (7.30) 29 -16.70 (5.50) 1.5 0.30 [ -2.20, 2.80 ]
Whatley 1994 16 -17.70 (4.20) 7 -13.10 (2.40) 1.2 -4.60 [ -7.32, -1.88 ]
Subtotal (95% CI) 223 144 18.1 -0.55 [ -1.26, 0.16 ]
Test for heterogeneity chi-square=10.85 df=5 p=0.05 I² =53.9%
Test for overall effect z=1.52 p=0.1
04 Weight change - mean age < 45 years
Aggel-Leijssen 2001 20 -15.20 (6.30) 17 -14.80 (5.30) 0.6 -0.40 [ -4.14, 3.34 ]
Janssen 2002 25 -10.50 (3.60) 13 -10.00 (3.90) 1.4 -0.50 [ -3.05, 2.05 ]
Kiernan 2001 81 -6.90 (5.50) 71 -4.50 (5.70) 2.8 -2.40 [ -4.19, -0.61 ]
Ross 1996 22 -12.40 (3.90) 11 -11.40 (3.50) 1.3 -1.00 [ -3.63, 1.63 ]
Wadden 1997 91 -16.40 (7.30) 29 -16.70 (5.50) 1.5 0.30 [ -2.20, 2.80 ]
Whatley 1994 16 -17.70 (4.20) 7 -13.10 (2.40) 1.2 -4.60 [ -7.32, -1.88 ]
Subtotal (95% CI) 255 148 8.9 -1.61 [ -2.62, -0.60 ]
Test for heterogeneity chi-square=8.97 df=5 p=0.11 I² =44.3%
Test for overall effect z=3.12 p=0.002
05 Weight change - mean age > 45 years
Gordon 1997 19 -7.10 (2.90) 15 -5.80 (3.90) 1.6 -1.30 [ -3.67, 1.07 ]
Hays 2004 11 -4.80 (0.90) 11 -3.20 (1.20) 11.5 -1.60 [ -2.49, -0.71 ]
Nieman 1998 22 -7.80 (3.30) 26 -8.00 (3.10) 2.7 0.20 [ -1.62, 2.02 ]
Svendsen 1993 48 -10.30 (3.00) 50 -9.50 (2.80) 6.9 -0.80 [ -1.95, 0.35 ]
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(. . . Continued)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Wing 1998 31 -10.30 (7.70) 35 -9.10 (6.40) 0.8 -1.20 [ -4.64, 2.24 ]
Subtotal (95% CI) 131 137 23.5 -1.12 [ -1.75, -0.50 ]
Test for heterogeneity chi-square=3.46 df=4 p=0.48 I² =0.0%
Test for overall effect z=3.55 p=0.0004
Total (95% CI) 1230 927 100.0 -1.02 [ -1.32, -0.72 ]
Test for heterogeneity chi-square=43.21 df=32 p=0.09 I² =25.9%
Test for overall effect z=6.66 p<0.00001
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Analysis 03.02. Comparison 03 Exercise + diet versus diet alone, Outcome 02 Change in body mass index
(BMI)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 02 Change in body mass index (BMI)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderssen 1996 65 -2.20 (1.80) 52 -1.60 (1.80) 18.5 -0.60 [ -1.26, 0.06 ]
Hellenius 1993 39 -0.60 (1.00) 40 -0.30 (1.00) 41.0 -0.30 [ -0.74, 0.14 ]
Janssen 2002 25 -4.00 (1.10) 13 -4.00 (1.40) 10.4 0.00 [ -0.87, 0.87 ]
Kiernan 2001 81 -2.30 (1.80) 71 -1.60 (1.80) 24.2 -0.70 [ -1.27, -0.13 ]
Wing 1998 31 -3.70 (2.60) 35 -3.30 (2.20) 5.8 -0.40 [ -1.57, 0.77 ]
Total (95% CI) 241 211 100.0 -0.43 [ -0.71, -0.14 ]
Test for heterogeneity chi-square=2.37 df=4 p=0.67 I² =0.0%
Test for overall effect z=2.96 p=0.003
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Analysis 03.03. Comparison 03 Exercise + diet versus diet alone, Outcome 03 Change in systolic blood
pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 03 Change in systolic blood pressure (mmHg)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Gordon 1997 19 -12.50 (6.30) 15 -11.30 (12.10) 4.1 -1.20 [ -7.95, 5.55 ]
Hellenius 1993 39 -4.00 (9.60) 40 -7.00 (11.30) 8.7 3.00 [ -1.62, 7.62 ]
Stefanick 1998 91 -3.10 (7.60) 95 -2.60 (7.80) 37.9 -0.50 [ -2.71, 1.71 ]
Svendsen 1993 48 -11.00 (11.00) 50 -13.00 (12.00) 8.9 2.00 [ -2.55, 6.55 ]
Wing 1998 31 -12.30 (9.50) 35 -10.20 (9.20) 9.1 -2.10 [ -6.62, 2.42 ]
Wood 1991 81 -4.50 (8.00) 71 -4.10 (7.30) 31.3 -0.40 [ -2.83, 2.03 ]
Total (95% CI) 309 306 100.0 -0.11 [ -1.48, 1.25 ]
Test for heterogeneity chi-square=3.58 df=5 p=0.61 I² =0.0%
Test for overall effect z=0.16 p=0.9
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Analysis 03.04. Comparison 03 Exercise + diet versus diet alone, Outcome 04 Change in diastolic blood
pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 04 Change in diastolic blood pressure (mmHg)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Gordon 1997 19 -7.90 (4.30) 15 -7.50 (4.30) -0.40 [ -3.31, 2.51 ]
Hellenius 1993 39 -2.00 (8.00) 40 -6.00 (6.50) 4.00 [ 0.78, 7.22 ]
Stefanick 1998 91 -2.90 (5.60) 95 -1.10 (5.10) -1.80 [ -3.34, -0.26 ]
Svendsen 1993 48 -9.00 (8.00) 50 -7.00 (8.00) -2.00 [ -5.17, 1.17 ]
Wing 1998 31 -6.90 (10.40) 35 -6.20 (6.90) -0.70 [ -5.02, 3.62 ]
Wood 1991 81 -3.50 (4.90) 71 -2.30 (5.90) -1.20 [ -2.94, 0.54 ]
-10.0 -5.0 0 5.0 10.0
Diet + exercise Diet alone
77Exercise for overweight or obesity (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 03.05. Comparison 03 Exercise + diet versus diet alone, Outcome 05 Change in total serum
cholesterol (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 05 Change in total serum cholesterol (mmol/l)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 -0.45 (1.02) 40 -0.19 (0.97) -0.26 [ -0.70, 0.18 ]
Janssen 2002 25 -0.15 (0.48) 13 -0.83 (0.36) 0.68 [ 0.41, 0.95 ]
Stefanick 1998 91 -0.49 (0.53) 95 -0.27 (0.50) -0.22 [ -0.37, -0.07 ]
Svendsen 1993 48 -1.23 (0.70) 50 -1.40 (0.80) 0.17 [ -0.13, 0.47 ]
Wing 1998 31 -0.33 (0.61) 35 -0.49 (0.71) 0.16 [ -0.16, 0.48 ]
Wood 1991 81 -0.32 (0.70) 71 -0.40 (0.60) 0.08 [ -0.13, 0.29 ]
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Analysis 03.06. Comparison 03 Exercise + diet versus diet alone, Outcome 06 Change in serum triglycerides
(mmol/l)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 06 Change in serum triglycerides (mmol/l)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Hellenius 1993 39 -0.12 (0.62) 40 0.03 (0.39) 18.7 -0.15 [ -0.38, 0.08 ]
Janssen 2002 25 -0.31 (0.70) 13 -0.32 (1.60) 1.2 0.01 [ -0.90, 0.92 ]
Stefanick 1998 91 -0.10 (0.60) 95 -0.06 (0.70) 28.0 -0.04 [ -0.23, 0.15 ]
Svendsen 1993 48 -0.30 (0.46) 50 -0.50 (0.70) 18.0 0.20 [ -0.03, 0.43 ]
Wing 1998 31 -0.69 (1.45) 35 -0.30 (1.45) 2.0 -0.39 [ -1.09, 0.31 ]
Wood 1991 81 -0.24 (0.60) 71 -0.03 (0.50) 32.1 -0.21 [ -0.38, -0.04 ]
Total (95% CI) 315 304 100.0 -0.08 [ -0.18, 0.02 ]
Test for heterogeneity chi-square=8.96 df=5 p=0.11 I² =44.2%
Test for overall effect z=1.55 p=0.1
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Analysis 03.07. Comparison 03 Exercise + diet versus diet alone, Outcome 07 Change in serum HDL (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 07 Change in serum HDL (mmol/l)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Hellenius 1993 39 -0.03 (0.21) 40 0.01 (0.19) -0.04 [ -0.13, 0.05 ]
Janssen 2002 25 -0.06 (0.14) 13 -0.05 (0.24) -0.01 [ -0.15, 0.13 ]
Stefanick 1998 91 -0.01 (0.15) 95 -0.01 (0.13) 0.00 [ -0.04, 0.04 ]
Svendsen 1993 48 -0.10 (0.23) 50 -0.05 (0.31) -0.05 [ -0.16, 0.06 ]
Wing 1998 31 0.06 (0.16) 35 0.10 (0.17) -0.04 [ -0.12, 0.04 ]
Wood 1991 81 0.08 (0.18) 71 -0.05 (0.20) 0.13 [ 0.07, 0.19 ]
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Analysis 03.08. Comparison 03 Exercise + diet versus diet alone, Outcome 08 Change in fasting serum
glucose (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 03 Exercise + diet versus diet alone
Outcome: 08 Change in fasting serum glucose (mmol/l)
Study Diet + exercise Diet alone Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderssen 1996 65 -0.26 (0.60) 52 -0.21 (0.50) 21.8 -0.05 [ -0.25, 0.15 ]
Janssen 2002 25 -0.10 (0.50) 13 -0.10 (0.40) 10.1 0.00 [ -0.29, 0.29 ]
Stefanick 1998 91 -0.43 (0.53) 95 -0.43 (0.43) 44.9 0.00 [ -0.14, 0.14 ]
Wing 1998 31 -0.20 (0.40) 35 -0.20 (0.40) 23.2 0.00 [ -0.19, 0.19 ]
Total (95% CI) 212 195 100.0 -0.01 [ -0.10, 0.08 ]
Test for heterogeneity chi-square=0.19 df=3 p=0.98 I² =0.0%
Test for overall effect z=0.23 p=0.8
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Analysis 04.01. Comparison 04 High versus low intensity exercise with dietary change, Outcome 01 Weight
change in kilograms
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 01 Weight change in kilograms
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson 1999 20 -8.30 (3.80) 20 -7.90 (4.20) 20.2 -0.40 [ -2.88, 2.08 ]
Cox 2004 15 -11.66 (3.10) 14 -10.88 (3.30) 22.8 -0.78 [ -3.11, 1.55 ]
Jakicic 1995 27 -6.40 (4.50) 25 -8.90 (5.30) 17.3 2.50 [ -0.18, 5.18 ]
Janssen 2002 11 -11.10 (4.40) 14 -10.00 (3.00) 13.5 -1.10 [ -4.14, 1.94 ]
Leutholtz 1995 20 -15.70 (5.30) 20 -15.00 (8.40) 6.6 -0.70 [ -5.05, 3.65 ]
Ross 1996 11 -11.40 (3.50) 11 -13.20 (4.10) 12.3 1.80 [ -1.39, 4.99 ]
Whatley 1994 8 -19.60 (4.20) 8 -15.80 (4.20) 7.3 -3.80 [ -7.92, 0.32 ]
Total (95% CI) 112 112 100.0 -0.08 [ -1.20, 1.04 ]
Test for heterogeneity chi-square=8.95 df=6 p=0.18 I² =33.0%
Test for overall effect z=0.14 p=0.9
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Analysis 04.02. Comparison 04 High versus low intensity exercise with dietary change, Outcome 02 Change
in body mass index (BMI)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 02 Change in body mass index (BMI)
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Janssen 2002 11 -4.20 (1.20) 14 -3.90 (1.00) -0.30 [ -1.18, 0.58 ]
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Analysis 04.03. Comparison 04 High versus low intensity exercise with dietary change, Outcome 03 Change
in systolic blood pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 03 Change in systolic blood pressure (mmHg)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Anderson 1999 20 -7.00 (7.10) 20 -7.90 (11.60) 0.90 [ -5.06, 6.86 ]
-10.0 -5.0 0 5.0 10.0
High intensity Low intensity
Analysis 04.04. Comparison 04 High versus low intensity exercise with dietary change, Outcome 04 Change
in diastolic blood pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 04 Change in diastolic blood pressure (mmHg)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Anderson 1999 20 -2.90 (7.80) 20 2.40 (18.30) -5.30 [ -14.02, 3.42 ]
-10.0 -5.0 0 5.0 10.0
High intensity Low intensity
Analysis 04.05. Comparison 04 High versus low intensity exercise with dietary change, Outcome 05 Change
in serum cholesterol (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 05 Change in serum cholesterol (mmol/l)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Anderson 1999 20 -0.58 (0.40) 20 -0.50 (0.70) -0.08 [ -0.43, 0.27 ]
Janssen 2002 11 0.42 (0.60) 14 -0.60 (0.40) 1.02 [ 0.61, 1.43 ]
-1.0 -0.5 0 0.5 1.0
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Analysis 04.06. Comparison 04 High versus low intensity exercise with dietary change, Outcome 06 Change
in serum triglycerides (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 06 Change in serum triglycerides (mmol/l)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson 1999 20 -0.20 (0.20) 20 -0.19 (0.40) 87.3 -0.01 [ -0.21, 0.19 ]
Janssen 2002 11 -0.26 (0.50) 14 -0.35 (0.80) 12.7 0.09 [ -0.42, 0.60 ]
Total (95% CI) 31 34 100.0 0.00 [ -0.18, 0.19 ]
Test for heterogeneity chi-square=0.13 df=1 p=0.72 I² =0.0%
Test for overall effect z=0.03 p=1
-1.0 -0.5 0 0.5 1.0
High intensity Low intensity
Analysis 04.07. Comparison 04 High versus low intensity exercise with dietary change, Outcome 07 Change
in serum HDL (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 07 Change in serum HDL (mmol/l)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Anderson 1999 20 -0.13 (0.20) 20 -0.14 (0.10) 63.5 0.01 [ -0.09, 0.11 ]
Janssen 2002 11 -0.03 (0.20) 14 -0.09 (0.10) 36.5 0.06 [ -0.07, 0.19 ]
Total (95% CI) 31 34 100.0 0.03 [ -0.05, 0.11 ]
Test for heterogeneity chi-square=0.36 df=1 p=0.55 I² =0.0%
Test for overall effect z=0.71 p=0.5
-0.5 -0.25 0 0.25 0.5
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Analysis 04.08. Comparison 04 High versus low intensity exercise with dietary change, Outcome 08 Change
in serum glucose (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 04 High versus low intensity exercise with dietary change
Outcome: 08 Change in serum glucose (mmol/l)
Study High Intensity Low Intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Janssen 2002 11 -0.10 (0.50) 14 -0.10 (0.40) 0.00 [ -0.36, 0.36 ]
-1.0 -0.5 0 0.5 1.0
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Analysis 05.01. Comparison 05 High versus low intensity exercise without dietary change, Outcome 01
Weight change in kilograms
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 01 Weight change in kilograms
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Cox 2004 13 -1.55 (2.40) 17 -0.44 (1.80) 26.9 -1.11 [ -2.67, 0.45 ]
Irwin 2003 87 -1.30 (3.60) 86 0.10 (3.40) 60.1 -1.40 [ -2.44, -0.36 ]
Jakicic 2003 49 -8.90 (7.30) 49 -6.30 (5.60) 9.9 -2.60 [ -5.18, -0.02 ]
Wallace 1997 8 -4.20 (4.10) 8 -1.90 (5.10) 3.2 -2.30 [ -6.83, 2.23 ]
Total (95% CI) 157 160 100.0 -1.47 [ -2.28, -0.66 ]
Test for heterogeneity chi-square=1.09 df=3 p=0.78 I² =0.0%
Test for overall effect z=3.56 p=0.0004
-10.0 -5.0 0 5.0 10.0
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Analysis 05.02. Comparison 05 High versus low intensity exercise without dietary change, Outcome 02
Change in systolic blood pressure (mmHg)
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 02 Change in systolic blood pressure (mmHg)
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Cox 1996 13 -3.60 (4.15) 17 -3.20 (3.38) -0.40 [ -3.17, 2.37 ]
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Analysis 05.03. Comparison 05 High versus low intensity exercise without dietary change, Outcome 03
Change in diastolic blood pressure
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 03 Change in diastolic blood pressure
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Cox 1996 13 -2.90 (2.20) 17 -3.10 (3.10) 0.20 [ -1.70, 2.10 ]
-10.0 -5.0 0 5.0 10.0
High intensity Low intensity
Analysis 05.04. Comparison 05 High versus low intensity exercise without dietary change, Outcome 04
Change in serum triglycerides (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 04 Change in serum triglycerides (mmol/l)
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Wallace 1997 8 -0.49 (0.15) 8 -0.36 (0.14) -0.13 [ -0.27, 0.01 ]
-1.0 -0.5 0 0.5 1.0
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Analysis 05.05. Comparison 05 High versus low intensity exercise without dietary change, Outcome 05
Change in serum HDL (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 05 Change in serum HDL (mmol/l)
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Wallace 1997 8 0.13 (0.03) 8 0.07 (0.04) 0.06 [ 0.03, 0.09 ]
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Analysis 05.06. Comparison 05 High versus low intensity exercise without dietary change, Outcome 06
Change in serum glucose (mmol/l)
Review: Exercise for overweight or obesity
Comparison: 05 High versus low intensity exercise without dietary change
Outcome: 06 Change in serum glucose (mmol/l)
Study High intensity Low intensity Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Cox 2004 13 -0.01 (0.50) 17 0.51 (1.00) 6.7 -0.52 [ -1.07, 0.03 ]
Wallace 1997 8 -0.62 (0.16) 8 -0.33 (0.14) 93.3 -0.29 [ -0.44, -0.14 ]
Total (95% CI) 21 25 100.0 -0.31 [ -0.45, -0.16 ]
Test for heterogeneity chi-square=0.63 df=1 p=0.43 I² =0.0%
Test for overall effect z=4.21 p=0.00003
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